PCV98 USE OF ELECTRONIC MEDICAL RECORDS TO ASSESS THE CLINICAL AND ECONOMIC IMPACT OF NON-MEDICAL SWITCHING BETWEEN DIFFERENT ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (Englisch)
- Neue Suche nach: Kamal, K. M.
- Neue Suche nach: Zacker, C.
- Neue Suche nach: Civitarese, L.
- Neue Suche nach: Kamal, K. M.
- Neue Suche nach: Zacker, C.
- Neue Suche nach: Civitarese, L.
In:
VALUE IN HEALTH
;
14
, 3
;
A50
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PCV98 USE OF ELECTRONIC MEDICAL RECORDS TO ASSESS THE CLINICAL AND ECONOMIC IMPACT OF NON-MEDICAL SWITCHING BETWEEN DIFFERENT ANGIOTENSIN RECEPTOR BLOCKERS (ARBS)
-
Beteiligte:
-
Erschienen in:VALUE IN HEALTH ; 14, 3 ; A50
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:A50
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 14, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A1
-
CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTINGBonafede, R. P. / Pearson, D. / Babich, J. / Chastek, B. / Becker, L. / Watson, C. / Chaudhari, S. / Harrison, D. J. / Gandra, S. R. et al. | 2011
- A4
-
SB3 INNOVATIVE DESIGN FOR A COMPARATIVE EFFECTIVENESS STUDY OF SCHIZOPHRENIA TREATMENTS: ANALYSIS OF RECORD REVIEW DATA INCORPORATING RANDOMIZATION AND PROPENSITY SCORE MATCHINGMcCarrier, K. P. / Durkin, M. B. / Dirani, R. / Markowitz, M. / Slabaugh, S. L. / Martin, M. L. et al. | 2011
- A5
-
CE4 USING DYNAMIC TRANSMISSION MODELS TO ESTIMATE THE COST EFFECTIVENESS OF VACCINES: FOUR DIFFERENT METHODS AND THEIR RELEVANCE FOR DECISION MAKERSMauskopf, J. / Talbird, S. E. / Standaert, B. et al. | 2011
- A8
-
MC3 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIASAn, J. J. / Nichol, M. B. et al. | 2011
- A9
-
EE4 BOOTSTRAPPING USED TO PROVIDE ROBUST MEAN AND VARIANCE ESTIMATES FOR COMPARING PATIENTS TREATED WITH LIRAGLUTIDE TO A LARGE COMPARISON COHORTMcAdam Marx, C. / Ye, X. / Bouchard, J. / Aagren, M. / Conner, C. / Brixner, D. et al. | 2011
- A10
-
MD1 USING COST-EFFECTIVENESS INFORMATION TO ALLOCATE MEDICARE RESOURCES – HOW MUCH MORE HEALTH FOR THE MONEY?Chambers, J. D. / Cohen, J. T. / Neumann, P. J. / Lord, J. / Buxton, M. et al. | 2011
- A12
-
PHP4 WHEN STAKEHOLDERS DON'T AGREE: DISCREPANCIES IN MAB “APPROVALS” OVER THE PAST TEN YEARSMiller, K. L. / Stevens, C. A. et al. | 2011
- A13
-
PHP10 THE TEMPORAL ASSOCIATION BETWEEN PRESCRIBED OPIOIDS AND THE NATIONAL DEATH RATE DUE TO OPIOID POISONINGGokhale, M. N. / Martin, B. et al. | 2011
- A14
-
PHP16 ANALYZING THE EUROPEAN EXTERNAL REFERENCE PRICING SYSTEM USING SPECTRAL GRAPH THEORYLindgren, P. / kerborg, x. et al. | 2011
- A15
-
PHP23 THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGSSepulveda, B. / Doyle, J. / White, C. et al. | 2011
- A16
-
PHP28 COMPLIANCE WITH TREATMENT GUIDELINE RECOMMENDATIONS: USE OF OVER-THE-COUNTER MEDICATIONS IN PATIENTS RECEIVING BISPHOSPHONATES, ANTIEPILEPTICS, OR CHRONIC OPIOIDSBarnes, K. D. / Heaton, P. C. et al. | 2011
- A17
-
PHP35 DECISION MAKING IN BRAZIL BASED ON HEALTH TECHNOLOGY ASSESSMENT: THE GOOD, THE BAD, AND THE FUTUREMachado, M. / Fonseca, E. / Fonseca, M. et al. | 2011
- A18
-
PHP41 THE CHANGING LANDSCAPE OF ORPHAN DRUG PROVISION IN THE EU5 AND THE UNITED STATESMcConkey, D. et al. | 2011
- A20
-
PHP52 INCREASE IN UNINTENTIONAL FATAL POISONINGS BY NOXIOUS SUBSTANCES IN KANSAS CITY, MISSOURI, FROM 1999 TO 2008Liu, Y. / Cai, J. / Hong, L. / Hoff, G. L. / Okah, F. A. et al. | 2011
- A21
-
PHP59 THE AVAILABILITY AND SIGNIFICANCE OF COST-EFFECTIVENESS DATA FOR INFORMING DECISIONS TO ADD NEW DRUGS TO THE NATIONAL LIST OF HEALTH SERVICES IN ISRAELGreenberg, D. / Wacht, O. / Siebzehner, M. I. et al. | 2011
- A22
-
PHP64 THE RELATIONSHIP BETWEEN FINANCIAL IMPACT AND THE LIKELIHOOD OF DRUG REIMBURSEMENT IN THE AUSTRALIAN HEALTH CARE SYSTEMMauskopf, J. / Chirila, C. / Masaquel, C. / Boye, K. S. / Bowman, L. / Birt, J. / Grainger, D. et al. | 2011
- A23
-
PHP69 HOW MUCH FOR A QALY IN KOREAKim, Y. / Shin, S. / Park, S. / Song, H. / Park, J. / Bae, E. / Ahn, J. et al. | 2011
- A24
-
PHP74 CLINICAL TRIAL LEARNING CURVES AFFECT OUTCOMES MEASUREMENT, PATIENT SAFETY AND TRIAL SUCCESS: CONTRIBUTING FACTORS AND A POTENTIAL SOLUTION IN CLINICAL TRIAL SIMULATIONSpinner, D. S. / Walter, J. W. / Vazquez-Gragg, M. / Bloise, T. / Stafford-Smith, M. / Faulkner, E. C. / Taekman, J. M. et al. | 2011
- A25
-
PHP80 RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION AMONG FUTURE PHARMACISTSSura, S. D. / Chabria, A. / Sansgiry, S. et al. | 2011
- A26
-
PHP85 APPLYING FUZZY MULTIPLE CRITERIA DECISION MAKING TO ESTABLISH A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM WITH COVERAGE IMPLICATIONS IN TAIWAN NATIONAL HEALTH INSURANCELin, C. W. et al. | 2011
- A27
-
PHP90 TRENDS IN UTILIZATION OF PREGNANCY RISK CATEGORY D AND X DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATESShah, A. J. / Patil, D. S. / Kadakia, A. / Aparasu, R. R. et al. | 2011
- A28
-
PHP95 EXPECTED CHANGES IN HEALTH CARE UTILIZATION DUE TO PATIENT PROTECTION AND AFFORDABLE CARE ACTGhushchyan, V. H. / Sullivan, P. W. / Naim, A. / Nair, K. V. et al. | 2011
- A30
-
PHP106 DISPARITY IN ACCESS TO NOVEL DIABETIC AGENTS FOR MEDICARE PART D ELDERLY COMPARED TO COMMERCIAL INSURED PATIENTS: INSIGHT INTO DOWNSTREAM EFFECTS OF CMS FORMULARY COVERAGE GUIDELINES FOR PDP'SSchwartz, E. L. / Davis, E. A. / Belazi, D. / Hasan, S. et al. | 2011
- A31
-
PHP112 DEFINITIONAL CRITERIA FOR CHRONIC FATIGUE SYNDROME: A CRITICAL REVIEWChristley, Y. / Duffy, T. / Martin, C. R. et al. | 2011
- A32
-
PCV3 RISK OF HOSPITALIZATIONS FOR VENOUS THROMBOEMBOLISM IN ATYPICAL VERSUS TYPICAL ANTIPSYCHOTIC USERS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES: A CLAIMS DATA ANALYSISDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
- A34
-
PCV15 PREDICTORS OF THE COMBINED DIAGNOSIS HYPERLIPIDEMIA AND HYPERTENSION - A NHANES 2007-2008 STUDYBhounsule, P. / Abughosh, S. et al. | 2011
- A35
-
PCV20 PERSISTENCE WITH STATINS AND PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS: A POPULATION-BASED COHORT STUDYChodick, G. / Shalev, V. / Goldstein, I. / Porath, A. / Simah, V. et al. | 2011
- A37
-
PCV31 ASSOCIATION BETWEEN HEART FAILURE AND IN-HOSPITAL MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTIONPhatak, H. / Pan, X. / Kawabata, H. et al. | 2011
- A38
-
PCV36 EVALUATION OF THE HOSPITAL RESOURCE UTILIZATION ASSOCIATED WITH TOLVAPTAN USAGE AMONG HEART FAILURE PATIENTS WITH HYPONATREMIA FROM THE EVEREST TRIALDasta, J. F. / Chiong, J. R. / Kim, S. / Lin, J. et al. | 2011
- A39
-
PCV42 A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTIONRao, S. / Lin, F. J. / Ojo, O. / Patel, V. / Yu, S. / Zhan, L. / Touchette, D. R. et al. | 2011
- A40
-
PCV47 COST-EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN BRAZILPepe, C. / Machado, M. / Olimpio, A. / Canella, M. / Ramos, R. et al. | 2011
- A42
-
PCV58 ASSOCIATION BETWEEN HEART FAILURE AND RESOURCE UTILIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTIONPan, X. / Kawabata, H. / Phatak, H. et al. | 2011
- A43
-
PCV63 THE IMPACT OF CARDIOVASCULAR DISEASE HOSPITALIZATIONS ON CHANGES IN PATIENT ADHERENCE TO ANTIHYPERTENISVE DRUGS IN A MEDICAID POPULATIONYan, X. / Shaya, F. T. et al. | 2011
- A44
-
PCV68 FACTORS ASSOCIATED WITH NON-ADMINISTRATION OF ORDERED PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS DOSESShermock, K. M. / Shafir, V. / Streiff, M. B. / Lavallee, D. M. / Pinto, B. L. / Haut, E. / Kraus, P. / Efird, L. / Elder, S. / Rand, C. et al. | 2011
- A45
-
PCV74 ASSESSMENT OF KNOWLEDGE ABOUT HYPERTENSION (HTN) AMONG HYPERTENSIVE PATIENTS IN SOUTHERN PUNJAB, PAKISTANAtif, M. / Asif, M. / Saleem, F. / Ahmad, N. / Saqib, N. et al. | 2011
- A46
-
PCV79 IMPACT OF DISEASE MANAGEMENT PROGRAM “DE TODO CORAZON” OF MUTUAL SER HMO TO CONTROL CARDIOVASCULAR RISK, COHORT 2004-2009, COLOMBIAPaz, J. J. / Granados, C. E. / Morales, C. / Rodriguez, N. / Buitrago, L. A. / Guete, A. / Caceres, H. A. / Ramirez, P. / Pardo, R. et al. | 2011
- A47
-
PCV84 EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CAREMartinez Valverde, S. / Reyes Morales, H. / Castro Rios, A. / Perez Cuevas, R. / Klunder Klunder, M. / Salinas Escudero, G. et al. | 2011
- A48
-
PCV90 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG PATIENTS IN A LARGE EMPLOYER-BASED CLAIMS DATABASEZhao, Z. / Peng, X. / Bae, J. P. / Sponseller, C. A. / LeNarz, L. A. et al. | 2011
- A49
-
PCV95 USING COMPUTERIZED PHYSICIAN ORDER ENTRY OF ANTI-HYPERTENSIVE MEDICATIONS TO CONNECT INDICATIONS WITH PRESCRIBING AND IMPROVE PROBLEM LIST DOCUMENTATIONGalanter, W. / Walton, S. / Falck, S. / Rosencranz, H. / Adimadhyam, S. et al. | 2011
- A50
-
PCV100 HEALTH CARE UTILIZATION AND COSTS FOR A MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMPinto, S. L. / Partha, G. et al. | 2011
- A52
-
PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUESGandhi, P. K. / Ried, L. D. / Huang, I. C. / Kimberlin, C. / Kauf, T. / Suh, D. C. et al. | 2011
- A53
-
PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDRENBerbari, J. / Reynolds, S. / Heil-Ruess, M. / Iskedjian, M. et al. | 2011
- A56
-
PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASISMamolo, C. / Bushmakin, A. G. / Cappelleri, J. C. / Stewart, M. et al. | 2011
- A57
-
PSS25 MEDICATION ADHERENCE TO TOPICAL MEDICATIONS AND HEALTHCARE EXPENDITURES IN MEDICAID-ENROLLED CHILD WITH ATOPIC DERMATITISOu, H. T. / Feldman, S. R. / Balkrishnan, R. et al. | 2011
- A58
-
PSS30 BURDEN OF INFANTILE HEMANGIOMA: DEVELOPMENT OF A QUESTIONNAIRETaieb, C. / Voisard, J. J. / Ruiz, F. et al. | 2011
- A59
-
PSY6 TRANSFUSIONAL IRON OVERLOAD (TIO) MONITORING AND TREATMENT: FINDINGS FROM AN ELECTRONIC MEDICAL RECORDS REVIEW STUDY AT THE MOFFITT CANCER CENTER AND RESEARCH INSTITUTEDuh, M. S. / Wetzstein, G. / Guo, A. / Sasane, M. / Sarda, S. P. / Korves, C. / Wang, S. T. / Wei, R. / Clinton, B. / Ray, L. et al. | 2011
- A60
-
PSY11 BURDEN OF ILLNESS IN FIBROMYALGIA SYNDROME: THE PATIENTS' PERSPECTIVESLee, S. S. / Kim, S. H. / Kim, S. K. / Lee, C. K. / Lee, H. S. / Lee, S. H. / Park, Y. B. / Ko, S. K. / Park, H. J. et al. | 2011
- A61
-
PSY16 PROJECTING THE LIFETIME ECONOMIC COSTS OF OBESITY: A BMI TRAJECTORY-BASED MODELWang, B. C. / Garrison, L. / Alfonso-Cristancho, R. / Wong, E. / Flum, D. / Arterburn, D. / Sullivan, S. D. et al. | 2011
- A62
-
PSY21 COST-EFFECTIVENESS ANALISYS OF TREATMENT WITH AMFEPRAMONE (DIETHYLPROPION) IN OBESITY IN MEXICORamirez Ramirez, M. / Soto-Molina, H. / Rizzoli-Cordoba, A. / Delgado-Ginebra, I. / Pizarro-Castellanos, M. et al. | 2011
- A63
-
PSY26 IMPACT OF HYPONATREMIA ON PATIENT OUTCOMES AND HEALTH CARE RESOURCE UTILIZATION IN HOSPITALIZED PATIENTSDeitelzweig, S. / Amin, A. / Lin, J. / Belk, K. / Baumer, D. / Lowe, T. et al. | 2011
- A64
-
PSY31 HEMOPHILIA A: PATIENT IMPACT AND ECONOMIC BURDEN OF THE DISEASEStrandberg-Larsen, M. / Gater, A. / Thomson, A. et al. | 2011
- A65
-
PSY36 DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)Jolly, M. / Kosinski, M. / Garris, C. P. / Jhingran, P. M. / Mikolaitis, R. A. / Dennis, G. / Wallace, D. J. / Clarke, A. / Parke, A. / Dooley, M. A. et al. | 2011
- A66
-
PSY42 EPIDEMIOLOGY AND QALITY OF LIFE OF ANEMIC PATIENTS ON DIALYSIS IN RUSSIA: PATIENT-REPORTED DATAVorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. / Eliseeva, E. / Baev, V. / Vezikova, N. et al. | 2011
- A67
-
PSY47 WILLINGNESS TO PAY (WTP) FOR WEIGHT LOSS COACHING: RESULTS FROM THE POWER TRIALAlavi, R. / Appel, L. / Brancati, F. / Clark, J. / Mohr, P. / Daumit, G. et al. | 2011
- A69
-
PSY59 IMPACT OF OBESITY ON AGE-SPECIFIC PREVALENCE OF CHRONIC DISEASES IN THE UNITED STATESPatel, J. G. / Shah, A. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. L. et al. | 2011
- A70
-
PSY64 GE CENTRICITY® ELECTRONIC MEDICAL RECORDS STUDY: COMORBIDITIES AND BIOLOGIC EXPERIENCE AMONG PATIENTS RECEIVING GOLIMUMABTandon, N. / Carter, C. / Haas, S. / Gunnarsson, C. et al. | 2011
- A71
-
PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)Ma, Q. / Kauf, T. / Hall, A. G. et al. | 2011
- A72
-
PSY75 PREVALENCE RATIOS AGAINST ODDS RATIOS AS EFFECT MEASURES IN A CROSS-SECTIONAL STUDY OF OBESITY AND ITS CHRONIC COMORBID CONDITIONSPatel, J. G. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. et al. | 2011
- A73
-
PSY80 PRIORITIZATION AND WEIGHTING OF PATIENT-RELEVANT ENDPOINTS (PRES) AS PART OF THE IQWIGS EFFICIENCY FRONTIER METHOD IN GERMANYMü / hlbacher, A. / Bridges, J. F. / Bethge, S. / Dintsios, C. M. / Schwalm, A. / Nü / bling, M. et al. | 2011
- A74
-
PUK4 CUMULATIVE EXPOSURE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)Yarger, S. / Nwokeji, E. / Trice, S. / Chao, S. / Devine, J. / Potyk, R. / Gutke, G. / Bonnema, A. et al. | 2011
- A76
-
PUK14 A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CAREGanz, M. / Clemens, J. Q. / Anger, J. / Denevich, S. / Shah, D. / Carlson, A. / Wittek, M. R. / Pashos, C. et al. | 2011
- A77
-
PUK19 KIT73: PRELIMINARY REPORTS OF IMMUNOSUPRESSANT THERAPY PATTERNS IN A COHORT OF POST KIDNEY TRANSPLANT PATIENTS IN BRAZILCarvalho, D. D. / Garcia, V. / Abbud-Filho, M. / Nishikawa, A. M. / Asano, E. / Nita, M. E. / Szabo, S. M. / Levy, A. R. / Carvalho, J. F. / Donato, B. M. et al. | 2011
- A78
-
PUK24 USE OF BIOMARKERS IN PROPENSITY SCORE MATCHING TO MITIGATE CHANNELING BIAS IN A RETROSPECTIVE COHORT OF ESRD PATIENTSWilson, S. M. / Rubin, J. L. et al. | 2011
- A79
-
PMD5 OUTCOME STUDY OF DRUG ELUTING STENT (DES) VERSUS BARE METAL STENT (BMS) IN HONG KONG: A 6-MONTH PILOT STUDYLee, V. / Yan, B. / Chan, T. / Woo, A. / Lee, K. K. / Yu, C. M. et al. | 2011
- A80
-
PMD11 IDENTIFYING POTENTIAL DRIVERS OF COST SAVINGS WITH INSULIN ADMINISTRATION DEVICES IN TYPE-2 DIABETES IN THE UNITED STATESPollock, R. F. / Curtis, B. / Boye, K. S. / Timlin, L. / Valentine, W. J. et al. | 2011
- A81
-
PMD16 COMPARISON OF COST AND CLINICAL OUTCOMES OF OPEN VERSUS LAPAROSCOPIC THORACIC PROCEDURES IN THE UNITED STATESHashemi, L. / Minshall, M. E. et al. | 2011
- A82
-
PMD21 IS CYBERKNIFE A COST-EFFECTIVE OPTION FOR TREATING PROSTATE CANCER?Parthan, A. / Pruttivarasin, N. / Taylor, D. / Davies, D. / Yang, G. / Pawar, V. / Weinstein, M. et al. | 2011
- A85
-
PMD40 METHODOLOGICAL CONSIDERATIONS IN MODELING THE ECONOMIC VALUE OF DIAGNOSTIC ACCURACYFoley, K. / Lim, S. / Schulman, K. L. et al. | 2011
- A86
-
PSU4 SURGEON'S VOLUME-OUTCOMES RELATIONSHIP FOR LOBECTOMIES AND WEDGE RESECTIONS FOR CANCER USING VIDEO-ASSISTED THORACOSCOPIC TECHNIQUESDavid, G. / Gunnarsson, C. / Moore, M. / Howington, J. / Miller, D. / Maddaus, M. / McKenna, R. / Meyers, B. / Swanson, S. et al. | 2011
- A87
-
PSU9 ECONOMIC EVALUATION OF THE CURRENT TREND TOWARDS MORE UNCEMENTED FIXATION IN PRIMARY HIP ARTHROPLASTIES AND THE POTENTIAL IMPACT OF CHANGES OF THE DEVELOPMENT IN ENGLAND AND WALESKontekakis, A. / Gaiser, S. et al. | 2011
- A88
-
PSU14 HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS ON KIDNEY TRANSPLANT WAITING LIST - WHAT FACTORS REALLY MATTER?Ong, S. C. / Chow, W. L. / van der Erf, S. / Joshi, V. D. / Tee, P. S. / Lu, Y. M. / Kee, T. Y. et al. | 2011
- A89
-
PSU20 IS THERE INDICATION BIAS OF RETROSPECTIVE OBSERVATIONAL STUDY?Choi, J. E. / Jang, E. J. / Jung, S. Y. / Lee, E. J. / Lee, N. R. / Joo, C. K. et al. | 2011
- A91
-
PDB6 LONG-TERM EFFECTIVENESS OF MANAGING DIABETES WITH THE CHRONIC CARE MODEL: SIMULATIONS PERFORMED USING ARCHESZgibor, J. C. / Kuo, S. / Schuetz, C. A. / Roberts, M. S. / Cohen, M. D. et al. | 2011
- A92
-
PDB11 COMPARISON OF MULTIVARIABLE-ADJUSTED LOGISTIC REGRESSION WITH PROPENSITY SCORE-MATCHED, PROPENSITY SCORE-STRATIFIED, AND PROPENSITY SCORE-ADJUSTED LOGISTIC REGRESSION MODELSKhoza, S. / Barner, J. C. / Richards, K. et al. | 2011
- A94
-
PDB22 INSULIN GLARGINE PLUS OHAS VERSUS BIPHASIC INSULIN IN TYPE-2 DIABETES – A COST COMPARISONTilling, C. / Owens, D. / Keech, M. et al. | 2011
- A96
-
PDB32 ECONOMIC EVALUATION OF RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN CANADAHaig, J. / Lawrence, D. / Barbeau, M. / Blouin, J. / Cruess, A. et al. | 2011
- A97
-
PDB37 MAIL-ORDER PHARMACY USE AND MEDICATION ADHERENCE AMONG MEDICARE PART D BENEFICIARIES WITH DIABETESZhang, L. / Zakharyan, A. / Stockl, K. M. / Harada, A. S. / Curtis, B. S. / Solow, B. K. et al. | 2011
- A98
-
PDB43 TREATMENT COMPLIANCE TO DIABETES CARE: A CROSS-SECTIONAL STUDY FROM PAKISTANParveen, M. / Piyarali, S. et al. | 2011
- A99
-
PDB48 DO WE KNOW WHAT ARE THEY TRADING OFF? – A FEASIBILITY STUDY TO MEASURE QUALITY OF LIFE IN TAIWANESE TYPE-2 DIABETES OUTPATIENTS BY TIME-TRADE-OFF METHODHuang, L. H. / Chen, L. C. / Huang, Y. B. / Hwang, S. J. et al. | 2011
- A100
-
PDB53 PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN T2DM PATIENTS TERTIARY CARE HOSPITAL IN INDIARaval, A. D. / Dhanaraj, E. / Bhansali, A. et al. | 2011
- A101
-
PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCETriki, N. / Greenberg, D. / Mossinson, D. / Shani, S. et al. | 2011
- A102
-
PDB64 EVALUATION OF THE BURDEN OF ILLNESS OF TYPE-2 DIABETES MELLITUS IN A MEDICARE POPULATIONCostantino, M. E. / Song, F. / Stacy, J. N. / Aagren, M. / Bouchard, J. / Marrett, E. et al. | 2011
- A103
-
PDB69 EXENATIDE (BID) AND LIRAGLUTIDE (QD) TREATMENT PATTERNS AMONG TYPE-2 DIABETES PATIENTS IN GERMANYMiller, L. A. / Burudpakdee, C. / Zagar, A. / Bhosle, M. / Reaney, M. / Schabert, V. F. et al. | 2011
- A105
-
PIH4 COMPARATIVE EFFECTIVENESS OF BANKED DONOR MILK FOR PREMATURE INFANTS: EFFICIENCY OF A MILK BANK MODEL INTEGRATED IN A BLOOD BANK SETTINGRicher, E. / Dourdin, N. / Goetghebeur, M. et al. | 2011
- A106
-
PIH9 COSTS TO THE NATIONAL HEALTH INSURACE SCHEME OF THE FREE MATERNAL HEALTH SERVICE CHALLENGES AND IMPLICATIONS FOR SUSTAINABILITY IN GHANAOdame, E. et al. | 2011
- A108
-
PIH20 ECONOMIC EVALUATION OF THE USE OF EXOGENOUS PULMONARY SURFACTANTS IN PRETERM NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME IN MEXICAN POPULATION COVERED BY THE NEW GENERATION MEDICAL INSURANCESalinas Escudero, G. / Martinez Valverde, S. / Villasis Keever, M. A. / Garduñ / o Espinosa, J. / Reyes Ló / pez, A. / Muñ / oz Herná / ndez, O. et al. | 2011
- A109
-
PIH25 IMPACT OF PATIENT BEHAVIORS AND ATTITUDES ON TERIPARATIDE ADHERENCE IN A MEDICARE PART D POPULATIONFoster, S. / Hazel-Fernandez, L. A. / Uribe, C. / Song, F. / Thomas, N. / Burge, R. T. / Krohn, K. et al. | 2011
- A111
-
PIH37 DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONSAjmera, M. R. / Wilkins, T. L. / Sambamoorthi, U. et al. | 2011
- A112
-
PIH42 A NET BENEFIT FRAMEWORK (NBF) ANALYSIS OF CHART DATA FOR HAEMOPHILIA INHIBITOR PATIENTSWeatherall, J. / Mesterton, J. / Lindgren, P. / Dalen, J. et al. | 2011
- A113
-
PIN1 VACCINE-ASSOCIATED GUILLAIN-BARRE SYNDROME: A PHARMACOVIGILANCE ANALYSIS OF DATA IN THE UNITED STATES' VACCINE ADVERSE EVENT REPORTING SYSTEM (1990-2009)Ali, A. K. et al. | 2011
- A114
-
PIN6 TRENDS OF HEPATITIS A INCIDENCE FROM 2005 TO 2008Eisenberg, D. / Changolkar, A. K. / Misurski, D. A. et al. | 2011
- A116
-
PIN17 TREATMENT PATTERNS AND DRUG TREATMENT COSTS ASSOCIATED WITH NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)-BASED ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE HIV-1 INFECTED PATIENTSDiels, J. / Langham, S. / Nuyts, G. / Adriaenssen, I. et al. | 2011
- A117
-
PIN23 COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR (ATV+RTV) COMPARED WITH LOPINAVIR/RITONAVIR (LPV+RTV) IN TREATMENT-NAÏVE HIV-INFECTED PATIENTS IN MEXICO: A MODEL BASED ON THE CASTLE STUDYJuarez-Garcia, A. / Martinez-Rivera, G. / Donato, B. M. et al. | 2011
- A118
-
PIN29 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS WITH FAILURE TO VANCOMYCIN THERAPY IN MEXICOBriones, B. / Martinez Revelles, M. / Garcí / a-Contreras, F. et al. | 2011
- A119
-
PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSISTarride, J. E. / Burke, N. / von Keyserlingk, C. / O'Reilly, D. / Xie, F. / Goeree, R. et al. | 2011
- A120
-
PIN39 IMMUNIZATION BARRIERS AND SUGGESTED SOLUTIONS IN IRAQAl-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Basher, A. Y. et al. | 2011
- A121
-
PIN45 IMPACT OF GOVERNMENT SPONSORED POLIO CONTROL PROGRAM ON KNOWLEDGE, ATTITUDE AND PERCEPTION OF POLIO IN GENERAL COMMUNITY OF BAHAWALPUR, PAKISTANAtif, M. / Asif, M. / Sulaiman, A. / Saleem, F. / Ahmad, N. / Saqib, N. / Qamar, M. et al. | 2011
- A122
-
PIN52 MAPPING STATE AND FEDERAL IMMUNIZATION RECORDS POLICIESHedden, E. / Jessop, A. / Field, R. I. et al. | 2011
- A123
-
PMS4 THE ASSOCIATION BETWEEN TERIPARATIDE PERSISTENCE AND FRACTURE OUTCOMES IN A US CLAIMS DATABASEYu, S. / Foster, S. / Burge, R. / Anderson, J. / Gelwicks, S. / Meadows, E. et al. | 2011
- A124
-
PMS11 APPLYING THE STRATIFIED PROPENSITY SCORE MATCHING METHOD WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTSBaser, O. / Xie, L. et al. | 2011
- A125
-
PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASEPark, S. J. / Lee, E. K. et al. | 2011
- A126
-
PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSISAlfonso-Cristancho, R. / Serra, N. / Aiello, E. C. / Roa, C. N. et al. | 2011
- A127
-
PMS26 COST-EFFECTIVENESS MODELING IN OSTEOPOROSIS: A SYSTEMATIC LITERATURE REVIEW AND OVERVIEWSmolen, H. J. / Myers, J. A. / Smolen, L. J. et al. | 2011
- A128
-
PMS31 TITLE: THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAINvan der Velde, G. / Hincapié / C. / Schieir, O. / Coté / P. / Hogg-Johnson, S. / Paulden, M. / Krahn, M. et al. | 2011
- A129
-
PMS37 INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITISKirson, N. / Rao, S. / Birnbaum, H. G. / Kantor, E. / Wei, R. / Cifaldi, M. et al. | 2011
- A130
-
PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDYGagol, G. / Fernandez, N. / Rouanet, S. et al. | 2011
- A131
-
PMS47 EMPLOYABILITY-ADJUSTED-LIFE-YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLIMUMAB PLUS METHOTREXATE OR METHOTREXATE ALONEHan, C. / Gathany, T. / Tandon, N. / Hsia, E. et al. | 2011
- A136
-
PRS1 SEVERE ASTHMA EXACERBATIONS ASSOCIATED WITH LONG-ACTING BETA AGONISTS AMONG CHILDREN AND ADOLESCENTS WITH ASTHMAGuo, J. J. / Tsai, K. / Kelton, C. / Bian, B. / Wigle, P. et al. | 2011
- A137
-
PRS6 WATERPIPE SMOKING AMONG JORDANIAN ADULTS: PREDICTORS AND CORRELATESYang, M. / Abughosh, S. / Wu, I. H. / Sansgiry, S. / Peters, R. J. / Hawari, F. I. / Essien, E. J. et al. | 2011
- A138
-
PRS12 A NATIONAL SURVEY OF SOCIETAL COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SOUTH KOREAKim, J. / Park, S. / Kim, Y. / Lee, E. / Oh, Y. / Boo, Y. et al. | 2011
- A139
-
PRS17 COST EFFECTIVENESS OF TOP 20 HIGHEST SELLING DRUGSAggarwal, S. et al. | 2011
- A140
-
PRS22 COPD MAINTENANCE MEDICATION ADHERENCE: INFLUENCE ON HOSPITALIZATION AND SPENDING IN A MEDICARE POPULATIONSimoni-Wastila, L. / Wei, Y. J. / Qian, J. / Zuckerman, I. H. / Stuart, B. / Shaffer, T. / Dalal, A. / Bryant-Comstock, L. et al. | 2011
- A141
-
PRS27 THE DEVELOPMENT OF A PATIENT-REPORTED OUTCOME INSTRUMENT TO EVALUATE NIGHTTIME SYMPTOMS OF COPDPalsgrove, A. / Schaefer, M. / Hareendran, A. / Houghton, K. / Mocarski, M. / Carson, R. / Make, B. et al. | 2011
- A143
-
PRS38 EFFECT OF HAVING A PRESCRIPTION DRUG PLAN ON ASTHMA PATIENTS' USE OF CONTROLLER MEDICATIONSVaidya, V. / Peeters, M. / Partha, G. / Potnis, P. et al. | 2011
- A144
-
PRS43 REGRESSION VERSUS PROPENSITY MATCHING AS OUTCOME ANALYSIS ADJUSTMENT METHODS: EXAMPLE USING COPD INITIAL THERAPIESRoberts, M. / Dalal, A. A. et al. | 2011
- A145
-
PRM2 MEASURING DRUG THERAPY GUIDELINES ON OUTCOMES: A TUTORIALBaser, O. et al. | 2011
- A146
-
PRM8 LEGAL RESTRICTIONS ON THE USE OF QALYS IN PHARMACOECONOMIC ANALYSIS IN GERMANYGissel, C. / Goetz, G. / Repp, H. et al. | 2011
- A147
-
PRM13 COMPARISON OF DISCRETE EVENTS SIMULATION SOFTWARE FOR USE IN HEALTH ECONOMICS & OUTCOMES RESEARCHAnaya, P. et al. | 2011
- A148
-
PRM18 CAN UTILITIES EXCEED 1.0? EMPIRICAL EVIDENCE OF THE CEILING EFFECTSullivan, P. W. / Ghushchyan, V. H. et al. | 2011
- A150
-
PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSISPerampaladas, K. / Doble, B. M. / Xie, F. et al. | 2011
- A151
-
PRM35 DEVELOPMENT OF A CONCEPT LIST TO ENSURE COMPARABLE CONTENT VALIDITY BETWEEN ORIGINAL PRO QUESTIONNAIRES AND THEIR TRANSLATIONS: A REVIEW OF 15 YEARS OF LINGUISTIC VALIDATIONSMear, I. / Conway, K. et al. | 2011
- A152
-
PRM40 ISSUES CONCERNING THE TRANSLATION OF THE WORD ‘HASSLED' IN THE MORISKY MEDICATION ADHERENCE SCALE (MMAS-8)Griffin, A. / Wild, D. / Morisky, D. E. et al. | 2011
- A153
-
PRM46 R … YOU AWARE HOW USEFUL IT IS? THE VALUE OF CORRELATION COEFFICIENTS IN META-ANALYSISAl-Dakkak, I. / Patel, S. / Jen, M. H. / von Maltzahn, R. et al. | 2011
- A154
-
PCN2 SAFETY AND TREATMENT PATTERNS OF ANGIOGENESIS INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN THE UNITED KINGDOM: PRELIMINARY RESULTS OF AN ONGOING CHARTS REVIEW STUDYHawkins, R. / Wagstaff, J. / Nathan, P. / Sarda, S. P. / Vekeman, F. / Korves, C. / Dasgupta, S. / O'Mara, S. / Fitton, S. / Hayers, J. et al. | 2011
- A156
-
PCN12 RESOURCE UTILIZATION AND PERCEPTIONS OF MAJOR MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): RESULTS OF A DELPHI PANEL STUDYBollu, V. / Quintas-Cardama, A. / Flamm, M. / Lill, M. / Thirman, M. / Ravandi-Kashani, F. / Akard, L. / Talpaz, M. et al. | 2011
- A158
-
PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGSGarg, V. / Raisch, D. W. / Mckoy, J. / Trifilio, S. / Holbrook, J. / Samaras, A. T. / West, D. et al. | 2011
- A159
-
PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVELuporsi, E. / Mahi, L. / Moore, C. / Wernli, J. / Bugat, R. et al. | 2011
- A160
-
PCN34 LONG-TERM DIRECT MEDICAL COSTS IN PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA WHO RECEIVE FRONTLINE CHEMOTHERAPY WITH VERSUS WITHOUT RITUXIMAB - A SEER MEDICARE ANALYSISGriffiths, R. I. / Gleeson, M. L. / Mikhael, J. R. / Danese, M. D. et al. | 2011
- A161
-
PCN39 COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)Alemayehu, B. / Parry, D. / Engel-Nitz, N. M. / Kulakodlu, M. / Nathan, F. et al. | 2011
- A162
-
PCN46 HEALTH CARE EXPENDITURES, DISABILITY DAYS, AND RESOURCE UTILIZATION ASSOCIATED WITH CANCER IN EMPLOYER SETTINGS IN THE UNITED STATESTang, D. / Alberts, D. S. / Nevins, R. / Sullivan, S. / Skrepnek, G. H. et al. | 2011
- A164
-
PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?Djalalov, S. / Beca, J. / Hoch, J. et al. | 2011
- A166
-
PCN68 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB REISTANT PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIATaylor, M. / Lewis, L. / Lebmeier, M. / Wang, Q. et al. | 2011
- A167
-
PCN73 UTILISATION OF ANTINEOPLASTIC AGENTS IN SLOVAK REPUBLICGatialova, K. / Bellova, K. / Petrova, L. / Majtas, J. / Binder, R. et al. | 2011
- A168
-
PCN79 IMPACT OF NON-ADHERENCE TO IMATINIB ON PROGRESSION-FREE SURVIVAL AS 1ST TREATMENT FOR CHRONIC MYELOID LEUKEMIA IN BRAZIL: TWO YEARS FOLLOW UPFunke, V. A. / Moellmann-Coelho, A. / Asano, E. / Nita, M. E. / Donato, B. M. / Rahal, E. et al. | 2011
- A169
-
PCN84 PATIENTS' PREFERENCES FOR THE TREATMENT OF COLORECTAL CANCER: A DISCRETE CHOICE EXPERIMENT (DCE) SURVEYAlbassam, A. / Noyce, P. / Ashcroft, D. et al. | 2011
- A170
-
PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALSPeeters, P. / Casamayor, M. / Moï / se, P. / Holmstrom, S. et al. | 2011
- A172
-
PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF METASTATIC AND RECURRENT LOCALLY-ADVANCED HEAD AND NECK CANCER PATIENTSLe, T. K. / Winfree, K. B. / Yang, H. / Marynchenko, M. / Yu, A. P. / Frois, C. / Wu, E. Q. et al. | 2011
- A173
-
PCN106 RESEARCH ON THE FACTORS AFFECTING THE ADOPTION OF HIGH VALUE MEDICAL CONSUMES IN LESS DEVELOPED AREAS OF CHINAJing, W. / Guanglian, X. et al. | 2011
- A175
-
PCN117 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ISS STAGE AND ECOG STATUS IN MULTIPLE MYELOMAPashos, C. L. / Durie, B. G. / Mehta, J. / Toomey, K. / Terebelo, H. R. / Abonour, R. / Fonseca, R. / Gasparetto, C. / Narang, M. / Rifkin, R. M. et al. | 2011
- A176
-
PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASELepisto, E. M. / Vandergrift, J. L. / Kalemkerian, G. P. / Pisters, K. M. / Zornosa, C. / Rabin, M. S. / Reid, M. E. / Koczywas, M. / Otterson, G. A. / Ettinger, D. S. et al. | 2011
- A177
-
PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CAREHeron, L. / De Castro Carpeñ / o, J. / Chouaid, C. / Vergnenè / gre, A. / Bischoff, H. G. / Walzer, S. et al. | 2011
- A178
-
PCN131 REPRESENTING UNCERTAINTY IN CALIBRATED CANCER TREATMENT MODELS: A PRACTICAL APPROACHTaylor, D. C. / Leahy, K. J. / Weinstein, M. et al. | 2011
- A179
-
PCN137 COMPREHENSIVE REVIEW OF MANAGEMENT EFFICIENCY STRATEGIES AMONG ONCOLOGY PRACTICES: EXISTING EVIDENCE AND OPPORTUNITIES FOR FUTURE RESEARCHGorman, K. / Miller, R. / McGarvey, N. / Corey-Lisle, P. et al. | 2011
- A180
-
PGI4 PREDICTORS OF HEPATITIS C TREATMENT INITIATIONWagner, J. S. / Goren, A. et al. | 2011
- A181
-
PGI9 COMPARISON OF DIRECT MEDICAL COSTS AND SERVICES BY POINT OF SERVICE AND PRESCRIPTION COST FOR PERSONS WITH HEPATITIS-C WITH AND WITHOUT TREATMENTBrook, R. A. / Kleinman, N. L. / Smeeding, J. et al. | 2011
- A183
-
PGI20 IBS-C PATIENT SYMPTOM REPORTS: ANALYSIS OF EXPLORATORY OPEN-ENDED QUESTIONSCarson, R. T. / Lewis, B. E. / Shiff, S. J. / Johnston, J. M. / Dennee-Sommers, B. / Lasch, K. E. / Hwang, S. / Marquis, P. et al. | 2011
- A185
-
PMH3 RISK OF HIP FRACTURES IN ELDERLY MEDICARE BENEFICIARIES USING ATYPICAL OR TYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE ANALYSISDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
- A186
-
PMH9 RISK OF DEATH IN DUAL ELIGIBLE NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTSAparasu, R. R. / Mehta, S. / Chen, H. et al. | 2011
- A187
-
PMH14 CLINICAL EFFECTIVENESS ANALYSIS OF NALTREXONE VERSUS ACAMPROSATE AND PLACEBO IN ALCOHOL DEPENDENT PATIENTS TREATED WITH PSYCHOTHERAPYJarosz, J. / Miernik, K. / Wachal, M. / Walczak, J. et al. | 2011
- A188
-
PMH19 THE BUDGET IMPACT ANALYSIS OF NALTREXONE IN THE TREATMENT OF ALCOHOL-DEPENDENT PATIENTS IN POLANDWalczak, J. / Semeniuk, A. / Pacocha, K. / Nogas, G. et al. | 2011
- A189
-
PMH24 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL SUBSTANCE MEDICATIONS FOR ALCOHOL DEPENDENCYBaser, O. / Wang, L. / Xie, L. et al. | 2011
- A190
-
PMH29 ESTIMATION OF DIRECT COSTS OF TREATING SCHIZOPHRENIA FOR COMMUNITY-DWELLING UNITED STATES RESIDENTSDesai, P. / Lawson, K. / Barner, J. C. / Rascati, K. L. et al. | 2011
- A191
-
PMH35 COMPARISONS OF MENTAL HEALTH-RELATED MEDICAL CARE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF ORAL VERSUS LONG-ACTING INJECTABLE RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIAPark, H. / Kim, D. N. / Rascati, K. L. et al. | 2011
- A192
-
PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPYSvedsater, H. / Locklear, J. / Johal, S. / Stillman, I. O. et al. | 2011
- A193
-
PMH45 MEASURES OF MEDICATION ADHERENCE IN ORAL VERSUS LONG-ACTING RISPERIDONE IN TEXAS MEDICAID PATIENTS WITH SCHIZOPHRENIAKim, D. N. / Park, H. / Rascati, K. L. et al. | 2011
- A194
-
PMH50 A TIME-TRADE-OFF STUDY OF HEALTH-RELATED QUALITY OF LIFE ADVANTAGE OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC TREATMENT FOR SCHIZOPHRENIAOsborne, R. H. / Dalton, A. / Hertel, J. / Schrover, R. / Kingsford Smith, D. et al. | 2011
- A195
-
PMH55 THE BURDEN OF DIAGNOSED DEPRESSION AND SLEEP DIFFICULTIES ON QUALITY OF LIFE, WORK PRODUCTIVITY, AND RESOURCE USEGupta, S. / Goren, A. / Gabriel, S. / Kim, E. / Dupclay, L. et al. | 2011
- A196
-
PMH60 BIPOLAR DISORDER RESULTS IN SIGNIFICANT BURDEN ON CAREGIVERS: ANALYSIS OF DATA FROM A LARGE MULTINATIONAL LONGITUDINAL STUDY (WAVE-BD)Vieta, E. / Figueira, M. L. / Bellivier, F. / Souery, D. / Blasco-Colmenares, E. / Langosch, J. M. / Medina, E. et al. | 2011
- A197
-
PMH65 EFFECT OF PRESCRIPTION MONITORING PROGRAMS (PMP'S) ON OPIOID OVERDOSE ADMISSIONPainter, J. T. et al. | 2011
- A199
-
PMH76 PHARMACIST AND PHARMACY STAFF KNOWLEDGE AND ATTITUDES TOWARDS SUICIDE AND SUICIDE PREVENTION AFTER A NATIONAL VA TRAINING PROGRAMLavigne, J. E. / King, D. A. / Lu, N. / Knox, K. L. / Kemp, J. E. et al. | 2011
- A200
-
PMH81 RELATIONSHIP BETWEEN ADHERENCE TO ANTIDEPRESSANT TREATMENTS AND DEPRESSIVE RELAPSEJung, S. Y. / Shin, S. / Song, H. / Park, J. / Ahn, J. et al. | 2011
- A201
-
PND1 PRESCRIBING PATTERNS OF DRUGS HAVING ANTICHOLINERGIC ACTIVITY IN PATIENTS WITH ALZHEIMER'S DISEASEGala, S. D. / Gupte, K. P. / Wu, W. K. et al. | 2011
- A202
-
PND6 THE IMPACT OF SPECIALTY CARE PROGRAMS ON RELAPSES OF MULTIPLE SCLEROSIS USING ADMINISTRATIVE DATATang, J. / Levin, M. C. / Bailey, J. E. / Faris, R. J. / Hong, S. H. / Chang, C. F. / Wang, J. et al. | 2011
- A203
-
PND11 THE ECONOMIC BURDEN OF OSA IN EACH OF THE METABOLIC SYNDROME COMPONENTS LEVELSGreenberg-Dotan, S. / Yan, X. / Scharf, S. M. / Shaya, F. T. et al. | 2011
- A206
-
PND27 MEDICO-ECONOMIC EVALUATION OF LACOSAMIDE ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY EPILEPSY IN THE UNITED STATESBenhaddi, H. / Helmers, S. et al. | 2011
- A207
-
PND32 HEALTH RESOURCE UTILIZATION AND COSTS FOR MIGRANEURS IN SCOTLANDBloudek, L. M. / Hansen, R. N. / Liu, L. / Batty, A. J. / Varon, S. F. / Lipton, R. B. / Sullivan, S. D. et al. | 2011
- A208
-
PND38 THE HIDDEN TOLL OF CAREGIVER BURDEN IN MULTIPLE SCLEROSISStewart, M. / Phillips, A. / Edwards, N. / Gupta, S. / Goren, A. et al. | 2011
- A209
-
PND43 THE PATIENTSLIKEME® EPILEPSY COMMUNITY: A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSYde la Loge, C. / Dimova, S. / Massagli, M. / Wicks, P. et al. | 2011
- A210
-
PND48 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN CHRONIC NEUROMUSCULAR DISORDERBanks, P. / Martin, C. R. / Petty, R. et al. | 2011
- A211
-
PND54 RETROSPECTIVE DATABASE ANALYSIS OF FREQUENCY AND COSTS OF RELAPSES AMONG MULTIPLE SCLEROSIS PATIENTSBoklage, S. / Preblick, R. / Yaldo, A. / Golick, M. / Pocoski, J. et al. | 2011
- A212
-
PND59 MEDICATION TREATMENT PATTERNS FOR MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEMTakemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Duarte, G. G. / Moretti, A. I. / Santos, P. M. / Tolentino, A. C. et al. | 2011
- A213
-
PND64 APPLICATION OF PREDICTIVE MODELING TO CLASSIFY FREQUENT SNORING IDENTIFIED FROM ROUTINE MEDICAL EXAMINATIONS USING THE NHANES DATABASERow, B. et al. | 2011
- A215
-
ISPOR 16th Annual International Meeting Financial Disclosure Information for Research Presentations| 2011
- A223
-
ISPOR 16TH Annual International Meeting Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
-
PHP101 VALUE BASED PRICING: WHAT IS THE FUTURE FOR PATIENT ACCESS SCHEMES?Loveman, C. M. / Mallinson, M. / Areteou, T. / White, R. et al. | 2011
-
PHP107 BIOMARKERS: A CHANGING PARADIGM FOR DEVELOPMENTPardini, A. T. / Saraf, S. / Sparrowhawk, K. et al. | 2011
-
PCV35 COMPARISON OF MAJOR BLEEDING RELATED MORTALITY, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATIONBaser, O. / Du, J. / Xie, L. / Baser, E. et al. | 2011
-
PCV60 MEDICATION ADHERENCE, PERSISTENCE, AND HEALTH CARE COSTS FOR PATIENTS INITIATING STATIN THERAPY IN A MANAGED CARE POPULATIONZhao, Z. / Peng, X. / Bae, J. P. / Dungey, J. / Faries, D. E. / Sponseller, C. A. / Wetmore, S. / Yu, C. Y. / LeNarz, L. A. et al. | 2011
-
PCV81 SUSTAINING CLINICAL OUTCOMES OVER 24 MONTHS: IS MEDICATION THERAPY MANAGEMENT (MTM) THE ANSWER?Pinto, S. L. / Jania, A. W. / Coehrs, B. / Riepenhoff, C. et al. | 2011
-
PCV87 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG ELDERLY PATIENTSZhao, Z. / Peng, X. / Bae, J. P. / Sponseller, C. A. / LeNarz, L. A. et al. | 2011
-
PSS1 STEVENS-JOHNSON AND RED MAN SYNDROME: A CASE REPORT ON ADVERSE DRUG REACTIONS OF SIMULTANEOUS USE OF PHENYTOIN AND VANCOMYCINKler, S. K. et al. | 2011
-
PSY4 TRENDS IN HYPONATREMIA MANAGEMENT AND ASSOCIATED OUTCOMES IN HOSPITAL SETTINGS: INTERIM RESULTS FROM AN OBSERVATIONAL, PROSPECTIVE, MULTI-CENTER, GLOBAL REGISTRY IN HOSPITALIZED PATIENTSDasta, J. F. / Amin, A. / Chiong, J. R. / Greenberg, A. / Hauptman, P. J. / Verbalis, J. G. et al. | 2011
-
PSY8 DIRECT AND INDIRECT COSTS OF PRIVATELY-INSURED PATIENTS TREATED WITH OXYMORPHONE EXTENDED-RELEASE OR OXYCODONE CONTROLLED-RELEASE TABLETSKirson, N. Y. / White, A. / Birnbaum, H. G. / Schiller, M. / Waldman, T. / Ben-Joseph, R. / Summers, K. et al. | 2011
-
PSY12 BASELINE CHARACTERISTICS AND PRE–INDEX TOTAL HEALTH CARE AND RHEUMATOID ARTHRITIS-RELATED COSTS IN PATIENTS RECEIVING GOLIMUMAB THERAPYCarter, C. / Tandon, N. / Smith, D. et al. | 2011
-
PSY25 RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE COSTS AND WORK PRODUCTIVITY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASENaim, A. / DiBonaventura, M. / Lofland, J. / Freedman, D. et al. | 2011
-
PSY43 HEALTH-RELATED QUALITY OF LIFE IN UKRAINE PATIENTS WITH HEREDITARY COAGULOPATHIESVorobyev, P. / Borisenko, O. / Zhulyov, Y. / Krasnova, L. / Bezmelnitsyna, L. et al. | 2011
-
PSY54 APPLICATION OF THE NON-LINEAR BLINDER-OAXACA DECOMPOSITION TO STUDY RACIAL/ETHNIC DISPARITIES IN ANTI-OBESITY MEDICATION USEMehta, H. B. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. L. et al. | 2011
-
PSY58 DISPARITY IN OBESITY MANAGEMENT: UNDER-TREATMENT AMONG ELDERLY POPULATIONShah, A. J. / Patel, J. G. / Rajan, S. S. / Abughosh, S. / Masilamani, S. et al. | 2011
-
PSY73 PAIN MEDICATION USE AND DETERMINANTS OF OPIOIDS PRESCRIBING IN THE UNITED STATES OUTPATIENT SETTINGSRasu, R. / Cunningham, L. / Sohraby, R. / Knell, M. et al. | 2011
-
PUK1 INCIDENCE AND 30-DAY MORTALITY OF COMMUNITY ACQUIRED PNEUMONIA (CAP) IN THE MEDICARE FEE-FOR-SERVICE (FFS) POPULATIONRubin, J. L. / Li, S. / Yu, H. / Dunning, S. / Sato, R. et al. | 2011
-
PUK21 PATIENT CHARACTERISTICS ASSOCIATED WITH INITIATION OF OVERACTIVE BLADDER (OAB) DISCUSSION WITH A PHYSICIANBotros, S. / Chen, C. I. / Bavendam, T. / Zou, K. H. / Goren, A. / Gupta, S. et al. | 2011
-
PMD4 PERCEPTION OF IRON DEFICIENCY IN CLINICAL PRACTICES: MULTIDISCIPLINARY FRENCH SURVEY (SUPFER SURVEY)Lasocki, S. / Luporsi, E. / Jamin, C. / Darne, B. / Mahi, L. / Marteau, P. et al. | 2011
-
PMD12 GENDER DIFFERENCES IN TOTAL KNEE ARTHROPLASTY (TKA) POSTOPERATIVE PAIN MANAGEMENT IN THE UNITED STATESGraver, R. M. / Domyahn, M. / Read, C. E. / Menzie, A. M. / Feinglass, S. R. et al. | 2011
-
PMD20 COST-EFFECTIVENESS ANALYSIS OF A NEW INDEX FOR PROSTATE CANCER DETECTIONNichol, M. B. / Wu, J. / An, J. J. / Huang, J. T. / Denham, D. / Frencher, S. K. / Jacobsen, S. J. et al. | 2011
-
PMD35 SHORT TERM OUTCOMES ASSOCIATED WITH A CHANGE IN REIMBURSEMENT FOR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASEHaley, J. / Rasu, R. et al. | 2011
-
PMD36 FAILURE OF INTERNATIONAL ORGANIZATION FOR STANDARDIZATION GUIDELINES TO REPORT CLINICALLY RELEVANT INFORMATION ABOUT POINT-OF-CARE INR DEVICE PERFORMANCEShermock, K. M. / Lavallee, D. M. / Streiff, M. B. et al. | 2011
-
PSU13 MORBID OBESITY AND HEALTH RELATED QUALITY OF LIFETayyem, R. / Ali, A. / Atkinson, J. / Martin, C. R. et al. | 2011
-
PDB1 TREATMENT PATTERNS AND OUTCOMES AMONG OLDER EXENATIDE BID USERS COMPARED TO INSULIN GLARGINE USERSGaebler, J. A. / Schultz, J. F. / Blickensderfer, A. / Wenten, M. / Riedel, A. / Harley, C. et al. | 2011
-
PDB23 THE IMPACT OF TREATMENT MODIFICATION ON HEALTHCARE EXPENDITURE IN PATIENTS WITH TYPE-2 DIABETES INITIATING EXENATIDE BID OR INSULIN GLARGINEPawaskar, M. / Bonafede, M. / Johnson, B. H. / Fowler, R. / Hoogwerf, B. J. et al. | 2011
-
PDB51 IMPROVING HEALTH INSURANCE AND PREVENTIVE EFFORT AMONG DIABETIC PATIENTS: THE COLOMBIAN EXPERIENCETrujillo, A. J. / Vecino-Ortiz, A. I. / Ruiz Gó / mez, F. / Steinhardt, L. C. et al. | 2011
-
PDB66 COSTS OF THE PHARMACEUTICAL PROGRAM TO TREAT T2DM PATIENTS FROM HIPERDIA: GOVERNMENT HEALTH CARE PROGRAM FOR DIABETES AND HYPERTENSION POPULATION UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEMNasciben, V. / Melo, T. G. et al. | 2011
-
PDB67 IT PROCESSES IN CLINICAL PRACTICES FOR DIABETES PATIENTS TYPE IIHuttin, C. / Atwood, S. et al. | 2011
-
PMH68 FDA REGULATIONS AND ANTIDEPRESSANT UTILIZATIONCampbell, C. J. / Pickard, A. S. / Schumock, G. T. et al. | 2011
-
PIH12 INPATIENT COSTS OF LOW BIRTH WEIGHT AND PRE-TERM INFANTS IN THE UNITED STATES IN 2008Meyers, J. / Meyers, S. R. et al. | 2011
-
PIH19 COSTS AND EFFECTS OF A MULTIFACETED INTERVENTION TO IMPROVE THE QUALITY OF CARE OF CHILDREN IN DISTRICT HOSPITALS IN KENYABarasa, E. W. / Cleary, S. / English, M. et al. | 2011
-
PIH24 RACIAL DISPARITIES IN MEDICATION UNDERUSE: THE ROLE OF PATIENT SATISFACTION WITH CARECampbell, C. / Halanych, J. H. / Safford, M. M. / Pisu, M. et al. | 2011
-
PIH28 FATIGUE MANAGEMENT: EXAMPLE AT WOMEN WORKING IN PHARMACYTaieb, C. / Auges, M. / Rahhali, N. et al. | 2011
-
PIN5 THE PREVALENCE AND ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN CANADA AND LATIN AMERICA: A SYSTEMATIC REVIEWSzabo, S. M. / Donato, B. M. / Yuan, Y. / Bibby, M. / Jimenez-Mendez, R. / Levy, A. R. et al. | 2011
-
PIN10 ECOMOMIC EVALUATION OF DAPTOMYCIN COMPARE WITH STANDARD THERAPY IN THE TREATMENT OF STAPHYLOCOCCUS AUREUS BACTEREMIA WITH OR WITHOUT ENDOCARDITIS IN COLOMBIARosso, F. / Soto, R. / Ariza, J. G. / Rueda, J. D. / Rosselli, D. et al. | 2011
-
PIN22 COST-EFFECTIVENESS OF A CATCH-UP DOSE OF HEPATITIS B VACCINE IN COLOMBIAN ADOLESCENTSAlvis, N. / Romero, M. / Paternina, A. / De la Hoz, F. et al. | 2011
-
PIN25 COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF THE VARICELLA VACCINE IN COLOMBIADe la Hoz, F. / Alvis, N. / Gamboa, O. / Castañ / eda, C. / Paternina, A. et al. | 2011
-
PIN44 REAL-WORLD EVALUATION OF THE ECONOMIC IMPACT OF DURATION OF DRUG THERAPY IN THE TREATMENT OF HEPATITIS C VIRUS (HCV)McCombs, J. / Shin, J. / Hines, P. / Saab, S. / Yuan, Y. et al. | 2011
-
PIN51 IMPACT OF 2005 MEASLES OUTBREAK IN THE UNITED STATES ON IMMUNIZATION RATE AGAINST MEASLESDwibedi, N. / Cortina, J. et al. | 2011
-
PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATESBeaubrun, A. C. / Daugherty, J. B. et al. | 2011
-
PMS46 IMPACT OF ETANERCEPT ON WORK AND ACTIVITY IMPAIRMENT IN EMPLOYED PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITISWatson, C. / Cheng, A. / Hone, D. / Huang, B. / Bitman, B. / Huang, X. Y. / Gandra, S. R. et al. | 2011
-
PMS51 RACIAL DISPARITIES IN UTILIZATION OF BIOLOGIC AND DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN A CALIFORNIA MEDICAID POPULATION WITH RHEUMATOID ARTHRITISNichol, M. B. / Wu, J. / Harker, J. O. / Knight, T. K. / Wong, A. L. et al. | 2011
-
PMS58 BURDEN OF RHEUMATOID ARTHRITIS DISEASE FLARESBolge, S. / Tandon, N. / Ingham, M. / Gupta, S. et al. | 2011
-
PRS9 COMPARISON OF THE BURDEN AND COST DRIVERS OF COPD HOSPITALIZATION BETWEEN HISPANIC AND WHITE POPULATION IN THE UNITED STATESBorrego, M. / Roberts, M. / Petersen, H. / Kharat, A. A. / Blanchette, C. et al. | 2011
-
PRS40 TRENDS IN ANTIBIOTIC PRESCRIBING RATES IN AMBULATORY CARE SETTINGS FOR ADULTS IN THE UNITED STATES WITH NASOPHARYNGITIS, UPPER RESPIRATORY TRACT INFECTIONS AND BRONCHITIS FROM 2006 TO 2008Agrawal, R. / Shah, J. / Chopra, P. / Aparasu, R. R. et al. | 2011
-
PRS42 CONCOMITANT ASTHMA MEDICATION USE IN PATIENTS USING OMALIZUMAB: RESULTS FROM THREE LARGE INSURANCE CLAIMS DATABASESLafeuille, M. H. / Duh, M. S. / Zhang, J. / Wertz, D. / Gu, T. / Tang, J. / Lefebvre, P. et al. | 2011
-
PRM1 MEASURING COMORBIDITY: AN UPDATED CRITICAL REVIEW OF AVAILABLE METHODSHermansson, J. / Carlqvist, P. / Kennedy, K. / Pietri, G. et al. | 2011
-
PRM11 WHY ALGORITHM DOESN'T MATTER IN SYNDROMIC SURVEILLANCE: A COMPARISON OF SYNDROME CLASSIFICATION METHODSShin, J. / Strylewicz, G. / Doctor, J. et al. | 2011
-
PRM16 VALIDATION AND PSYCHOMETRIC EVALUATION OF A 5-ITEM MEASURE OF PERCEIVED SOCIAL SUPPORTMcCarrier, K. P. / Bushnell, D. M. / Martin, M. L. / Paczkowski, R. / Nelson, D. R. / Buesching, D. et al. | 2011
-
PRM19 NON-RESPONSE BIAS IN A SURVEY ASSESSING PATIENTS' MEDICATION AND HEALTH BELIEFSGadkari, A. / McHorney, C. / Pedan, A. / Gowda, N. et al. | 2011
-
PRM23 MEASURING THE IMPACT OF PREVIOUS TREATMENT CYCLES ON HEALTH UTILITY IN PATIENTS RECEIVING BOTULINUM TOXIN TYPE A (BONTA) IN A PROSPECTIVE OBSERVATIONAL COHORT STUDY: MOBILITY STUDYSimonyi, S. / Jog, M. / Wein, T. / Beauchamp, R. / Miller, R. / Ismail, F. / Bhogal, M. / Huang, B. et al. | 2011
-
PRM24 EXPLORING THE INTERRELATIONSHIP BETWEEN UNINTENTIONAL AND INTENTIONAL NONADHERENCE AMONG 24,071 ADULTS WITH CHRONIC DISEASEGadkari, A. / McHorney, C. et al. | 2011
-
PRM36 NONPARAMETRIC ESTIMATION OF INCREMENTAL COST EFFECTIVENESS RATIO ACCOUNTING FOR SKEWNESSBlough, D. K. et al. | 2011
-
PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTINGCraver, C. / Gayle, J. / Balu, S. / Buchner, D. et al. | 2011
-
PCN4 BODY MASS INDEX AND STAGE OF DIAGNOSIS OF OVARIAN CANCER: A SYSTEMATIC REVIEW AND META-ANALYSISBlieden, M. B. et al. | 2011
-
PCN55 RACIAL VARIATION IN THE COST-EFFECTIVENESS OF CHEMOTHERAPY FOR PROSTATE CANCERGrabner, M. / Onukwugha, E. / Jain, R. / Mullins, C. D. et al. | 2011
-
PCN54 INJECTION OF LONG-ACTING SOMATOSTATIN ANALOGS: A COST CONSEQUENCE ANALYSIS IN FRANCE, GERMANY, THE UNITED KINGDOM AND THE UNITED STATESRoze, S. / Kurth, H. / Maury le Breton, A. et al. | 2011
-
PCN80 PATIENT PREFERENCES FOR TOXICITIES ASSOCIATED WITH CHEMOTHERAPIES FOR ADVANCED BREAST CANCERBeusterien, K. / Grinspan, J. / Tencer, T. / Brufsky, A. / Visovsky, C. et al. | 2011
-
PCN104 HOSPITAL COSTS OF ADVERSE EVENTS IN PATIENTS RECEIVING TREATMENT FOR METASTATIC COLORECTAL CANCERFu, A. Z. / Zhao, Z. / Wang, S. / Gao, S. / Barber, B. / Liu, G. et al. | 2011
-
PCN123 A SYSTEMATIC REVIEW OF TREATMENT GUIDELINES FOR METASTATIC COLORECTAL CANCEREdwards, M. / Chadda, S. / Zhao, Z. / Barber, B. / Sykes, D. et al. | 2011
-
PCN125 MELODY BRASIL: TREATMENT PATTERNS AND ASSOCIATED COSTS OF METASTATIC MELANOMA PATIENTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)Stefani, S. / Schmerling, R. A. / Asano, E. / Nita, M. E. / Nishikawa, A. M. / Dias, K. M. / Donato, B. M. / Rahal, E. et al. | 2011
-
PMH8 EFFECT OF VARIOUS ANTIDEPRESSANT GROUPS ON BONE MINERAL DENSITY (BMD)Kurmanji, J. M. / Syed Sulaiman, S. A. / Chandrasekaran, P. K. / Kah, L. K. et al. | 2011
-
PMH15 IMPACT OF ADHERENCE TO FIRST THERAPY ON THE RISK OF ANTIDEPRESSANT SWITCHINGJung, S. Y. / Shin, S. / Song, H. / Park, J. / Ahn, J. et al. | 2011
-
PMH33 THE EFFECTIVENESS OF BUPRENORPHINE-MEDICATION ASSISTED TREATMENT AMONG AETNA'S OPIOID DEPENDENT MEMBERS: AN ANALYSIS OF HEALTH CARE COSTS AND SERVICE UTILIZATIONTkacz, J. / Un, H. / Leader, D. / Ruetsch, C. et al. | 2011
-
PMH52 PATIENT AND PHYSICIAN PREFERENCES AND SATISFACTION WITH ORAL AND LONG-ACTING INJECTABLE LONG-TERM ANTIPSYCHOTIC TREATMENT FOR PSHYCHOTIC DISORDERSPrû / tz, C. / Andersson-Ljungberg, G. / Hintikka, J. / Opjordsmoen, S. / Nielsen, J. / Hansson, F. et al. | 2011
-
PMH64 COMPARISON OF THE RISPERIDONE EQUIVALENT DOSES FOR THE 9 MOST FREQUENT TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA BASED ON PRODUCT LABELS WITH ACTUAL DOSAGES PRESCRIBED IN A LARGE NATIONAL DATABASEParente, A. K. / Wang, R. H. / Jones, B. T. et al. | 2011
-
PMH70 WHAT DROVE THE DRAMATIC SLOWDOWN IN PSYCHIATRIC DRUG SPENDING GROWTH IN THE UNITED STATESMark, T. et al. | 2011
-
PMH80 UTILIZATION PATTERN AND TREATMENT ADHERENCE WITH MOOD STABILIZERS AND ATYPICAL ANTIPSYCHOTICS AMONG PEDIATRIC PATIENTS WITH BIPOLAR DISORDER: A RETROSPECTIVE CLAIMS-BASED STUDYMehta, S. / Patel, A. / Chen, H. et al. | 2011
-
PND7 PREVALENCE OF DRUG-TREATED MULTIPLE SCLEROSIS WITHIN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM: COMPARATIVE ANALYSIS WITH PUBLISHED PREVALENCE RATESTakemoto, M. L. / Takemoto, M. M. / Fernandes, R. A. / Duarte, G. G. / Tolentino, A. C. / Santos, P. M. / Moretti, A. I. et al. | 2011
-
PND17 IMPACT OF WALKING AND MOBILITY PROBLEMS ON REQUIREMENT FOR HEALTHCARE AMONG MULTIPLE SCLEROSIS PATIENTSRajagopalan, K. / Pike, J. / Jones, E. / Anderson, P. et al. | 2011
-
PND19 HUMANISTIC AND ECONOMIC BURDEN IN TUBEROUS SCLEROSIS COMPLEX WITH NEUROLOGICAL MANIFESTATIONS: SYSTEMATIC REVIEWHallett, L. / Foster, T. / Valentim, J. / Blieden, M. / Liu, Z. et al. | 2011
-
PND24 QUALITY OF LIFE USING TREATMENTS FOR PARKINSON'S DISEASE: AN ECONOMIC COMPARISON BETWEEN ROPINIROLE AND LEVODOPA/CARBIDOPAPatil, D. S. / Shah, A. J. / Sansgiry, S. et al. | 2011
-
PND42 THE ASSOCIATION BETWEEN PARKININSON'S DISEASE QUESTIONNAIRE (PDQ) SCORES WITH CARER STRAIN AND QUALITY OF LIFEJenkinson, C. / Peters, M. / Fitzpatrick, R. / Churchman, D. et al. | 2011
-
PND44 HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS WITH DYSPORT IN CERVICAL DYSTONIAColeman, C. / Chang, S. / Copley-Merriman, C. / Masaquel, C. / Hubble, J. et al. | 2011
-
CN4 PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING AMONG MEDICARE PATIENTS WITH CANCERCraver, C. / Gayle, J. / Balu, S. / Buchner, D. et al. | 2011
-
DM3 IMPACT OF MONTHLY PRESCRIPTION CAP ON MEDICATION PERSISTENCY AMONG PATIENTS WITH DIABETES, HYPERTENSION, OR HYPERLIPIDEMIAWang, C. C. / Wei, D. / Farley, J. et al. | 2011
-
DU3 IMPACT OF THE FDA'S ANTIPSYCHOTIC BLACK BOX WARNING ON PSYCHOTROPIC DRUG PRESCRIBING IN ELDERLY PATIENTS WITH DEMENTIA IN OUTPATIENT AND OFFICE-BASED SETTINGSDesai, V. C. / Heaton, P. C. / Kelton, C. et al. | 2011
-
EV1 DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)Basch, E. M. / Abernethy, A. / Mullins, C. D. / Tiglao, M. R. / Tunis, S. R. et al. | 2011
-
PHP5 INCENTIVE-BASED INTERVENTIONS – REWARDING PATIENTS FOR GOOD BEHAVIOURHaynes, S. / Costello, S. / Brooks-Rooney, C. / Hamer, N. et al. | 2011
-
PHP18 OPTIMAL HEALTH POLICY AND THE LINK BETWEEN OUTPUT MARKETS AND DEVELOPMENTPhilipson, T. et al. | 2011
-
PHP48 STATUS OF PHARMACIST AT COMMUNITY LEVEL: AN EXPLORATORY STUDY IN QUETTA, PAKISTANSaleem, F. / Al-Qazaz, H. K. / Azhar, S. / Ahmad, N. / Atif, M. / Haq, N. / Asif, M. / Iqbal, Q. et al. | 2011
-
PHP72 ASSESSING THE QUALITY OF PHARMACOECONOMIC STUDIES IN INDIA: A SYSTEMATIC REVIEWDesai, P. / Chandwani, H. / Rascati, K. et al. | 2011
-
CO2 REAL-WORLD COST-EFFECTIVENESS ANALYSIS OF CANCER DRUGS: COMPARATIVE EFFECTIVENESS RESEARCH USING RETROSPECTIVE CANADIAN REGISTRY DATA BEFORE AND AFTER DRUG APPROVALKhor, S. / Krahn, M. / Hodgson, D. / Bremner, K. / Luo, J. / Hoch, J. et al. | 2011
-
Guide for Authors| 2011
-
OR2 ASSESSING THE RELATIONSHIP BETWEEN MEDICATION ADHERENCE AND EMPLOYEE PRODUCTIVITYLoeppke, R. / Haufle, V. / Jinnett, K. et al. | 2011
-
SB4 A METHODOLOGY FOR ASSESSING TREATMENT EFFECT IN THE PRESENCE OF DISEASE SEVERITY AND COMORBIDITY IN RETROSPECTIVE OBSERVATIONAL STUDIESKiri, V. A. et al. | 2011
-
CE3 COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ASSESSMENT: A GRAPHICAL WAY TO COMBINE THE TWO FOR THE AID OF DECISION-MAKERSPaulden, M. / Pham, B. et al. | 2011
-
DS2 A VALIDATION STUDY OF ALGORITHMS FOR IDENTIFYING METASTATIC BREAST, LUNG, OR COLORECTAL CANCER IN ADMINISTRATIVE CLAIMS DATAWhyte, J. L. / Engel-Nitz, N. M. / Teitelbaum, A. / Gomez Rey, G. / Kallich, J. et al. | 2011
-
PHP2 TRENDS IN AND PREDICTORS OF DISCOUNT GENERIC MEDICATION PROGRAM UTILIZATIONGatwood, J. / Tungol, A. / Truong, C. / Erickson, S. et al. | 2011
-
PHP14 THE EFFECTS OF PHARMACEUTICAL COST CONTAINMENT ON ACCESS TO LICENSED AND SUBSIDIZED MEDICINES UNDER SINGLE PAYER SYSTEMS IN THE UNITED STATES, UNITED KINGDOM, AUSTRALIA AND NEW ZEALANDRagupathy, R. / Aaltonen, K. / Tordoff, J. / Norris, P. / Reith, D. et al. | 2011
-
PHP24 NUMBER AND TYPE OF DRUGS USED BY SENIORS ON PUBLIC DRUG PROGRAMS IN CANADA, 2002 TO 2008Hunt, J. / Gaucher, M. et al. | 2011
-
PHP29 EVALUATING THE PERFORMANCE OF AN INNOVATIVE PUBLIC HEALTH INSURANCE: THE CASE OF A DECENTRALIZED PROVINCE IN ARGENTINAMaceira, D. et al. | 2011
-
PHP50 MIXED EVIDENCE FOR THE ”HEALTHY ADHERER EFFECT” IN A SAMPLE OF 22,070 ADULTS WITH CHRONIC DISEASE IN THE UNITED STATESMcHorney, C. / Gadkari, A. et al. | 2011
-
PHP62 WHAT IS THE IMPACT OF COMPARATIVE EFFECTIVENESS AND VALUE BASED PRICING ON A PRODUCT'S VALUE AND MARKET ACCESS?Walker, R. / Ng-Haing, J. / Koruth, R. / Sparrowhawk, K. et al. | 2011
-
PHP93 AN EXAMINATION OF HOSPITAL-ACQUIRED CONDITIONS BY AGE AND PAYER IN FIFTEEN STATES, 2008Maeda, J. L. / Parlato, J. / Levit, K. / Andrews, R. M. / Jiang, H. J. et al. | 2011
-
PHP96 REASONS FOR REJECTION OF PRO LABEL CLAIMS: AN ANALYSIS BASED ON A REVIEW OF PRO USE AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010DeMuro, C. / Clark, M. / Mordin, M. / Evans, E. / Copley-Merriman, K. / Fehnel, S. E. / Gnanasakthy, A. et al. | 2011
-
PCV8 EVALUATION OF A SAFETY INITIATIVE AND OUTCOMES FOR PATIENTS ON STATIN-FIBRATE COMBINATION THERAPIES IN THE VETERANS AFFAIRS POPULATIONYi, T. / Tran, J. N. / Bounthavong, M. et al. | 2011
-
PCV16 MANAGING GROWING POPULATION OF TYPE-2 DIABETES FROM COMMUNITY TO TEACHING HOSPITALS IN CHINAZhang, D. / Ji, L. / Hu, D. et al. | 2011
-
PCV24 EVALUATION OF THE CLINICAL FACTORS AND PREVENTIVE MEDICATIONS ASSOCIATED WITH THE LENGTH OF HOSPITAL STAY AMONG ISCHEMIC STROKE PATIENTSAl-Jabi, S. W. / Hassan, Y. / Abd Aziz, N. / Looi, I. / Zyoud, S. H. et al. | 2011
-
PCV34 PROPHYLAXIS USE AND 90-DAY COSTS FOR VENOUS THROMBOEMBOLISM, MAJOR AND MINOR BLEEDING EVENT ANALYSIS IN HOSPITALIZED MEDICALLY ILL PATIENTSBaser, O. / Xie, L. / Yuce, H. / Du, J. / Wang, L. et al. | 2011
-
PCV52 COST-EFFECTIVNESS STUDY OF CITICOLINE IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN RUSSIAVorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. et al. | 2011
-
PCV64 ADHERENCE TO MEDICATIONS WITH ONCE-A-DAY (QD) AND TWICE-A-DAY (BID) DOSING FORMULATIONS IN ACUTE CORONARY SYNDROME (ACS) PATIENTSHess, G. / Bhandary, D. / Fonseca, E. / Kumar, D. / Potter, D. / Smith, D. / Gandhi, S. K. et al. | 2011
-
PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIADennee-Sommers, B. / Galipeau, N. / Fitzgerald, K. / Evans, C. / Daniels, S. / Burgess, S. M. et al. | 2011
-
PSY20 ECONOMIC EVALUATION OF SEQUENTIAL ANALGESIC TREATMENT IN THE MANAGEMENT OF MODERATE ANKLE SPRAIN IN MEXICAN ADULTSArreola-Ornelas, H. / Rosado-Buzzo, A. / Garcia-Mollinedo, M. / Muciñ / o-Ortega, E. / Mould-Quevedo, J. F. / Galindo-Suarez, R. M. et al. | 2011
-
PUK5 TREATMENT PATTERNS IN OVERACTIVE BLADDER: REAL-WORLD PATIENT POPULATIONEllsworth, P. / Bavendam, T. / Zou, K. H. / Mastey, V. / Chen, C. I. et al. | 2011
-
PUK11 UPDATED ECONOMIC ANALYSIS OF FESOTERODINE RELATIVE TO TOLTERODINE AND SOLIFENACIN FOR THE TREATMENT OF OVERACTIVE BLADDER: THE SWEDISH PERSPECTIVELee, R. / Snedecor, S. J. / Kvasz, M. G. / Trocio, J. / Borgman, B. et al. | 2011
-
PUK17 UTILIZATION AND ECONOMIC IMPACT OF IV IRON AND ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE PATIENTS: A MULTI-HOSPITAL STUDYJoshi, A. D. / Holdford, D. / Brophy, D. / Harpe, S. E. et al. | 2011
-
PMD10 SCREENING TREATMENT AND CONTROL OF HYPERTENSION IN DIABETIC PATIENTS USING OUTPATIENT VISIT DATASurbhi, S. / Mackey, M. L. et al. | 2011
-
PSU2 USING ELECTRONIC MEDICAL RECORDS TO IDENTIFY POTENTIAL PREDICTORS FOR BARIATRIC SURGERY SUCCESSBenoit, S. / Hunter, T. D. / Steinbuch, M. / Fegelman, E. / Francis, D. / Seeley, R. et al. | 2011
-
PSU18 IMPACT OF HEALTH INSURANCE ON RECEIVING BREAST CONSERVING SURGERY WITH RADIATION IN FLORIDAAli, A. A. / Xiao, H. et al. | 2011
-
PDB5 THE IMPACT OF ANTIDIABETIC-INDUCED HYPOGLYCEMIA ON CLINICAL OUTCOMES AND RESOURCE UTILIZATION AMONG VETERANS WITH TYPE-2 DIABETES MELLITUS (T2DM)Zhao, Y. / Shi, L. / Fonseca, V. / Campbell, C. et al. | 2011
-
PDB16 DIABETES MELLITUS TYPE 2 AND T2DM PLUS HYPERTENSION IN BRAZIL: THE EPIDEMIOLOGIC PROFILE OF THE POPULATION REGISTERED IN THE GOVERNMENT PROGRAM HIPERDIANasciben, V. / Melo, T. G. et al. | 2011
-
PDB20 BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF SAXAGLIPTIN IN THE TREATMENT OF TYPE-2 DIABETES IN CHILEElgart, J. / Caporale, J. / Aiello, E. C. / Gagliardino, J. J. / Waschbusch, M. / Jotimliansky, L. / Valencia, J. E. et al. | 2011
-
PDB34 PHARMACOECONOMIC EVALUATION OF A PHARMACIST-MANAGED DIABETES CLINICTan, P. S. / Pt, T. et al. | 2011
-
PDB76 DESIGNING A SERVICE FRAMEWORK FOR ELECTRONIC PERSONAL HEALTH RECORDS: A PATIENT-CENTRED APPROACHLeyland, M. / Archer, N. / Deal, K. / Hassanein, K. et al. | 2011
-
PIH5 RISK OF HIP AND SUBTROCHANTERIC OR DIAPHYSEAL FEMORAL FRACTURES IN ALENDRONATE USERSHsiao, F. Y. / Huang, W. F. / Chen, Y. M. / Wen, Y. W. / Kao, Y. H. / Chen, L. K. / Tsai, Y. W. et al. | 2011
-
PIH44 MULTIDOMAIN LONGITUDINAL MODELING: APPLICATION TO THE INTERNATIONAL INDEX OF ERECTILE FUNCTIONBushmakin, A. G. / Cappelleri, J. C. / Symonds, T. / Stecher, V. et al. | 2011
-
PIN14 ECONOMIC BURDEN OF SEVERE SEPSIS IN A VERTICALLY INTEGRATED HEALTH CARE SYSTEM (IHS)Choe, Y. / Lamerato, L. / Zervos, M. / Stern, L. / Hendlish, S. / Ogbonnaya, A. / Fain, R. et al. | 2011
-
PIN20 A COST BENEFIT ANALYSIS OF ANTI-RETROVIRAL (ARVS) DRUGS IN THE TREATMENT OF HIV IN UGANDAMwanje, A. / Kangenyi, F. et al. | 2011
-
PIN27 COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF ACELLULAR PERTUSSIS IN COLOMBIAN ADOLESCENTSDe la Hoz, F. / Alvis, N. / Moreno, J. / Alvis, L. / Paternina, A. et al. | 2011
-
PIN53 COMPARISON OF EVIDENCE-BASED VARIATION AND CONSTANT PERCENTAGE VARIATION FOR ONE-WAY SENSITIVITY ANALYSESMcQueen, R. B. / Libby, A. / Campbell, J. et al. | 2011
-
PMS24 THE COST EFFECTIVENESS OF STRONTIUM RANELATE VERSUS RISEDRONATE, RALOXIFENE, IBANDRONATE, ALENDRONATE AND CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN TURKEYMalhan, S. / Cetin, A. / Gur, A. / Kavuncu, V. / Tan, M. et al. | 2011
-
PMS36 EXAMINING THE RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE COSTS AND WORK PRODUCTIVITY AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITISNaim, A. / DiBonaventura, M. / Bolge, S. et al. | 2011
-
PMS50 PATTERNS OF TREATMENT UTILIZATION FOR OSTEOPOROSIS IN ELDERLY WOMEN RESIDING IN THE COMMUNITY AND IN LONG-TERM CARE FACILITIESLoh, F. E. / Stuart, B. et al. | 2011
-
PMS62 ASSOCIATION OF SATISFACTION WITH SUBCUTANEOUS ANTI-TNF THERAPY AND CLINICAL OUTCOMES, HEALTH STATUS, AND LOST WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITISBolge, S. / Tandon, N. / Gupta, S. et al. | 2011
-
PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIALKavanaugh, A. / McInnes, I. / Krueger, G. G. / Gladman, D. / Beutler, A. / Gathany, T. / Mudivarthy, S. / Mack, M. / Tandon, N. / Han, C. et al. | 2011
-
PRS18 THE COST-EFFECTIVENESS OF ROFLUMILAST IN THE MANAGEMENT OF SEVERE COPD IN THE UK SETTINGKotchie, R. / Samyshkin, Y. / Zammit, D. C. / Humphreys, S. / Jameson, K. et al. | 2011
-
PRS20 A COST-UTILITY ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICOGarcí / a-Contreras, F. / Zuñ / iga, G. / Briones, B. et al. | 2011
-
PRS32 HOSPITAL COST VERSUS MEDICARE PAYMENT FOR RESPIRATORY INSUFFICIENCY, ARREST AND FAILUREAgarwal, S. J. / Erslon, M. G. / Bloom, J. D. et al. | 2011
-
PRS34 PATIENT SELF-MANAGEMENT OF ASTHMA: A STUDY IN AN EMERGENCY ROOM OF A CHEST HOSPITAL IN DELHI, INDIAKotwani, A. / Shendge, S. / Vijayan, V. et al. | 2011
-
PRM22 STAGES OF NON-PERSISTENCE: A NOVEL WAY OF FRAMING LONGITUDINAL PERSISTENCE TO CHRONIC MEDICATIONSGadkari, A. / McHorney, C. et al. | 2011
-
PRM41 IS IT TIME TO ELIMINATE THE ICER? USING NET BENEFITS TO REPORT THE RESULTS OF DETERMINISTIC COST-EFFECTIVENESS ANALYSESO'Day, K. / McLaughlin, T. / Bramley, T. et al. | 2011
-
PCN7 COMPARATIVE EFFECTIVENESS ASSESSMENT OF ERLOTINIB VERSUS GEFITINIB IN FIRST-LINE EGFR ACTIVATING MUTATION POSITIVE NON-SMALL CELL LUNG CANCERSchwander, B. / de Castro Carpeñ / o, J. / Heigener, D. F. / Wright, E. / Bischoff, H. G. / Walzer, S. et al. | 2011
-
PCN53 RISK OF PERSONAL BANKRUPTCY FOLLOWING A CANCER DIAGOSISKirchhoff, A. C. / Fedorenko, C. R. / Snell, K. / Blough, D. K. / Hollingworth, W. / Ramsey, S. et al. | 2011
-
PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCERCraver, C. / Gayle, J. / Balu, S. / Buchner, D. et al. | 2011
-
PCN65 ECONOMIC EVALUATION OF THREE FORMULATIONS OF LEUPROLIDE ACETATE IN ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER IN PORTUGALWex, J. / Sidhu, M. / Odeyemi, I. / Retsa, P. et al. | 2011
-
PCN77 USE OF SUBSTANCE ABUSE AMONG RESIDENTS OF KARACHI: REASONS AND COST OF USING SUBSTANCESParveen, M. et al. | 2011
-
PCN81 DIVERSITY IN BELIEFS ABOUT THE CAUSES OF CANCER: A QUALITATIVE APPROACH TO EVALUATE CANCER PATIENTS' UNDERSTANDING TOWARDS CANCER AND ITS CAUSESFarooqui, M. / Hassali, M. A. / Knight, A. / Shafie, A. A. / Tan, B. S. / Farooqui, M. A. et al. | 2011
-
PCN91 ARTHRALGIA AND PATIENT-REPORTED OUTCOMES IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER TAKING AROMATASE INHIBITORS: LONGITUDINAL ANALYSESCastel, L. D. / Mayer, I. A. / Chen, H. / McLellan, S. E. / Deppen, S. A. / Abramson, V. G. / Boomershine, C. S. / Friedman, D. L. / Gundy, C. M. / Lenderking, W. R. et al. | 2011
-
PCN99 ITALIAN MONITORING REGISTRY OF BEVACIZUMAB IN THE TREATMENT OF METASTATIC COLON RECTAL CARCINOMASiviero, P. D. / Montilla, S. / De Nigro, L. / Foggi, P. / Tomino, C. / Rasi, G. et al. | 2011
-
PCN135 ECONOMIC CONSEQUENCES OF PREVENTABLE BLADDER TUMOR RECURRENCES IN NON-MUSCLE INVASIVE BLADDER CANCERLee, C. T. / Globe, D. / Colayco, D. / Gilmore, A. / Bramley, T. et al. | 2011
-
PGI8 COMPARING HEALTH-RISK BURDEN, LOST PRODUCTIVITY, AND TOTAL HEALTHCARE COSTS AMONG INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE AND FIVE MOST PREVALENT CHRONIC DISEASESNaim, A. / Pitts, J. / Chen, C. Y. / Wright, D. / Chalk, M. B. / Edington, D. et al. | 2011
-
PGI17 HCV TREATMENT CONTINUATION RATES IN GENOTYPE 1 PATIENTS IN A REAL-WORLD SETTING IN THE UNITED STATESDiels, J. / Gavart, S. / Nuyts, G. et al. | 2011
-
PGI18 FEASIBILITY OF ASSESSING UTILITY BY EQ-5D AND TIME-TRADE-OFF METHODS IN TAIWANESE CHRONIC HEPATITIS B PATIENTSLin, Y. T. / Chen, L. C. / Huang, Y. B. / Huang, J. F. et al. | 2011
-
PMH10 THE INFLUENCE OF COMORBID ANXIETY ON MEDICATION USE AND SERVICE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: RESULTS FROM A RETROSPECTIVE CLAIMS DATABASEWu, C. H. / Farley, J. et al. | 2011
-
PMH22 CLINICAL AND ECONOMIC CONSEQUENCES OF LONG-TERM USE OF BENZODIAZEPINES IN PATIENTS WITH GENERALIZED ANXIETY DISORDERBerger, A. / Edelsberg, J. / Treglia, M. / Alvir, J. / Oster, G. et al. | 2011
-
PMH21 DIFFERENCES IN DAILY AVERAGE CONSUMPTION AND DAILY COSTS OF DESVENLAFAXINE, VENLAFAXINE XR, DULOXETINE, AND ESCITALOPRAM AMONG COMMERCIALLY INSURED PATIENTSWhiteley, J. / Makin, C. / Klingman, D. / Alvir, J. / Harnett, J. et al. | 2011
-
PMH32 COMPARISON OF REAL-WORLD HEALTH CARE COSTS AFTER THE INITIATION OF SECOND-LINE DULOXETINE OR GENERIC SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH MAJOR DEPRESSIIVE DISORDERSwindle, R. / Ivanova, J. I. / Birnbaum, H. G. / Cummings, A. K. / Kantor, E. / Schiller, M. / Clark, T. / Reed, C. et al. | 2011
-
PMH46 THE EFFECT OF ANTIPSYCHOTIC ADHERENCE ON ADHERENCE TO DIABETES, HYPERLIPIDEMIA, AND HYPERTENSION MEDICATIONS AND ASSOCIATED HEALTH SERVICE UTILIZATIONFarley, J. / Hansen, R. / Yu-Isenberg, K. / Maciejewski, M. et al. | 2011
-
PMH59 DIFFERENCES IN BASELINE PROBLEM SEVERITY BETWEEN PRESCRIPTION AND STREET OPIOID ABUSERS AMELIORATED AFTER PARTICIPATION IN DISEASE MANAGEMENT PROGRAM: RESULTS AT ONE YEARTkacz, J. / Ruetsch, C. et al. | 2011
-
PMH67 CO-PRESCRIBING CHOLINESTERASE INHIBITORS WITH ANTICHOLINERGIC URINARY INCONTINENCE MEDICATIONSStephens, M. / Heaton, P. et al. | 2011
-
PND31 HEADACHE DAY HEALTH STATES AND TRANSITION PROBABILITIES FOR PATIENTS WITH CHRONIC MIGRAINE WITH AND WITHOUT HEADACHE PROPHYLAXISBloudek, L. M. / Hansen, R. N. / Liu, L. / Batty, A. J. / Varon, S. F. / Lipton, R. B. / Sullivan, S. D. et al. | 2011
-
PND63 LITTLE OR NO TREATMENT EFFECT? APPLICATION OF GROWTH MIXTURE MODELS TO EXPLORE UNKNOWN SUBGROUPS OF DIFFERENTIAL RESPONDERS TO TREATMENTStull, D. E. / Houghton, K. / Wesnes, K. et al. | 2011
-
Copyright/Subscription| 2011
-
CE1 COST-EFFECTIVENESS SENSITIVITY ANALYSIS METHODS: A COMPARISON OF ONE-WAY SENSITIVITY, ANALYSIS OF COVARIANCE, AND EXPECTED VALUE OF PARTIAL PERFECT INFORMATIONCampbell, J. / McQueen, R. B. / Libby, A. / Briggs, A. et al. | 2011
-
MD4 EVALUATION OF AN INTERVENTION TO REDUCE POLY-PHARMACY IN MEDICARE PART DLivengood, K. B. / Harrell, T. / Abarca, J. et al. | 2011
-
PHP7 DEVELOPING PUBLIC HEALTH GUIDANCE - WHAT ARE THE DATA GAPS? REVIEW OF THE GAPS IN THE EVIDENCE IDENTIFIED BY NICE IN THE UNITED KINGDOMKusel, J. / Costello, S. / Hamer, N. / Roper, S. / Hamerslag, L. et al. | 2011
-
PHP25 THE POTENTIAL VALUE OF THE 2014 MEDICAID EXPANSIONSepulveda, B. / Doyle, J. et al. | 2011
-
PHP46 THE STATE OF HEALTH ECONOMIC EVALUATION IN SOUTH AFRICA: A SYSTEMATIC REVIEWGavaza, P. / Rascati, K. L. / Oladapo, A. O. / Khoza, S. et al. | 2011
-
PHP55 THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL)Ofierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. et al. | 2011
-
PHP84 AHRQ VERSUS NICE: DO THE CONCLUSIONS IN CER REPORTS CORRESPOND CLOSELY TO THE COMPARATIVE EFFECTIVENESS ASSESSMENTS MADE IN HTA REPORTS?Alnwick, K. et al. | 2011
-
PHP88 INFLUENCE OF HOSPITAL CHOICES OF DRUGS ON THE PHARMACEUTICAL CONSUMPTION IN THE COMMUNITYGallini, A. / Legal, R. / Taboulet, F. et al. | 2011
-
PHP91 ASSOCIATION BETWEEN QUALITY OF CARE AND SHORT TERM OUTCOMES FOR VERY OLD PATIENTS HOSPITALIZED FOR ACUTE ILLNESSESChong, W. F. / Ding, Y. Y. / Sun, Y. / Heng, B. H. et al. | 2011
-
PHP113 IQWIG AND HIQA, WHAT ARE THEY GOOD FOR? THE EVOLUTION OF THE HTA AGENCY: TIME FROM CREATION TO FIRST ASSESSMENT AND IMPACTFUL APPRAISALGreen, M. J. et al. | 2011
-
PCV6 ANALYSIS OF MYOCARDIAL INFARCTION RELATED CLINICAL OUTCOMES, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATIONWang, L. / Xie, L. / Baser, O. et al. | 2011
-
PCV11 PNEUMONIA AFTER ACUTE ISCHEMIC STROKE: PREVALENCE, ASSOCIATED FACTORS AND OUTCOMESAl-Jabi, S. W. / Hassan, Y. / Abd Aziz, N. / Looi, I. / Zyoud, S. H. et al. | 2011
-
PCV48 COST-EFFECTIVENESS ANALYSIS OF ANTIARRHYTHMIC THERAPIES FOR THE TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA AND SURGICALLY INDUCED TACHYCARDIAS AND HYPERTENSIONDexter, F. / Yang, J. / Carlton, R. / Bramley, T. / Harb, G. et al. | 2011
-
PCV53 COST-EFFECTIVENESS ANALYSIS COMPARING IVABRADINE WITH ISOSORBIDE MONONITRATE, AMLODIPINE, DILTIAZEM AND VERAPAMIL, IN THE TREATMENT OF STABLE ANGINA PECTORISErgene, O. / Erol, M. K. / Oto, A. / Kucukoglu, S. / Ozdemir, O. / Tan, M. et al. | 2011
-
PCV76 PATIENT SYMPTOM EXPERIENCES FOLLOWING A MYOCARDIAL INFARCTIONGwaltney, C. / Martin, M. L. / Falvey, H. et al. | 2011
-
PCV78 HEALTH RELATED QUALITY OF LIFE IN HYPERTENSIVE PATIENTS VISITING PUBLIC HOSPITALS OF QUETTA, PAKISTANSaleem, F. / Hassali, M. A. / Shafie, A. A. / Bashir, S. et al. | 2011
-
PCV107 IDENTIFYING EFFICIENT ACUTE CLINICAL PATHWAYS FOR CHEST PAIN: USING RISK ADJUSTED COST-EFFECTIVENESS (RAC-E) TO COMPARE HOSPITALS USING LINKED, ROUTINELY COLLECTED DATACaffrey, O. / Pham, C. / Karnon, J. / Ben-Tovim, D. I. / Hakendorf, P. / Crotty, M. et al. | 2011
-
PCV109 BEYOND CASE FATALITY: A NEW METHOD TO ESTIMATE THE EFFECT OF INCREASING TREATMENT UPTAKE ON MORTALITYMitsakakis, N. / Wijeysundera, H. C. / Krahn, M. et al. | 2011
-
PSS11 COST-EFFECTIVENESS ANALYSIS OF FORMULARY MANAGEMENT STRATEGIES FOR FIRST-LINE AGENTS USED IN OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSIONBlaser, D. A. / Ousterhout, M. M. / Gagnon, J. M. / Calabrese, D. et al. | 2011
-
PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACHDuran, A. / Spaepen, E. / Lamotte, M. / Walter, E. / Lucioni, C. / Pinheiro, B. / Brosa, M. / Kutikova, L. / Pujol, B. / Annemans, L. et al. | 2011
-
PSY32 HOW DO MINIMALLY IMPORTANT DIFFERENCES VALUE OUTCOMES?Suh, J. K. / Doctor, J. et al. | 2011
-
PSY38 PATIENT-REPORTED OUTCOMES IN SUBJECTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY: PAIN DESCRIPTION AND QUALITY OF LIFEKo, K. S. / Cha, B. Y. / Kim, C. H. / Kwon, H. S. / Lee, J. H. / Park, T. S. / Won, J. C. / Ko, S. K. / Park, H. J. et al. | 2011
-
PSY45 CHARACTERISTICS OF CAREGIVERS AND THEIR EXPERIENCE ASSOCIATED WITH CONGENITAL HEMOPHILIA OF INHIBITOR PATIENTSWisniewski, T. / Petrilla, A. A. / DeKoeven, M. / Lee, W. C. / Cooper, D. L. / Holot, N. / von Mackensen, S. et al. | 2011
-
PSY74 TREATMENT CHOICE FOR PAIN MANAGEMENT IN NURSING HOME HOSPICE/PALLIATIVE CARE RESIDENTS IN THE UNITED STATESAgrawal, R. / Mhatre, S. K. / Sansgiry, S. et al. | 2011
-
PSY77 COMPARISON OF OBESITY-ASSOCIATED COMORBIDITIES BETWEEN EMR AND CLAIMS DATABASESBrixner, D. / Bron, M. / Bellows, B. K. / Ye, X. / Harikrishnan, V. / Oderda, G. et al. | 2011
-
PSY81 PERCEPTIONS ABOUT 'RAPID' WARFARIN REVERSAL WITH FRESH FROZEN PLASMA TO REDUCE THE INR: A NOVEL SURVEY METHODOLOGYPetrozzino, J. / Hoesche, J. / Jones, C. et al. | 2011
-
PMD2 A META-ANALYSIS OF BIOMARKERS AND DIAGNOSTIC IMAGING IN ALZHEIMER'S DISEASESullivan, S. D. / Bloudek, L. / Spackman, D. E. / Blankenburg, M. et al. | 2011
-
PMD1 IMPACT OF VAGUS NERVE STIMULATION (VNS) THERAPY ON CLINICAL OUTCOMES AND COSTS IN MEDICAID PATIENTS WITH DRUG-RESISTANT EPILEPSYDuh, M. S. / Faught, E. / Guerin, A. / Sarda, S. P. / Samuelson, T. / Bunker, M. T. / Olin, B. D. / Jackson, S. D. / Helmers, S. L. et al. | 2011
-
PMD9 ESTIMATION OF QUALITY-ADJUSTED LIFE EXPECTANCY AND LOSS OF QUALITY-ADJUSTED LIFE EXPECTANCY IN PATIENTS UNDER PROLONGED MECHANICAL VENTILATION: A POPULATION-BASED STUDY DURING 1998-2007 IN TAIWANHung, M. C. / Wang, J. D. et al. | 2011
-
PMD13 POST INGUINAL HERNIA REPAIR PAIN MANAGEMENT COSTS: A STUDY USING THE PREMIER PERSPECTIVE ™ DATABASE (PPD)Morseon, M. / Hashemi, L. et al. | 2011
-
PMD17 ANALYSIS OF COST DRIVERS IN STRUCTURED SMBG IN POORLY CONTROLLED, NON-INSULIN TREATED TYPE-2 DIABETES: RESULTS FROM THE STEP STUDYMyers, J. / Berndt, K. / Wegmann, N. / Rees, C. / Mast, O. / Wagner, R. et al. | 2011
-
PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIOChen, W. / Ellis, P. / Levin, L. / Krahn, M. et al. | 2011
-
PMD30 IMPACT OF ACCESS TO A USUAL SOURCE OF CARE ON COMPLIANCE TO BREAST AND CERVICAL CANCER SCREENINGDatar, M. V. / Wu, W. K. et al. | 2011
-
PMD34 PREFERENCES FOR GENETIC TESTING TO ASSESS COLON-CANCER RISKSMohamed, A. F. / Johnson, F. R. / Knight, S. J. et al. | 2011
-
PSU11 REDUCTION IN HEALTHCARE UTILIZATION AND EXPENDITURES IN PATIENTS TREATED WITH CATHETER ABLATION FOR ATRIAL FIBRILLATION (AF) IN THE UNITED STATESLadapo, J. A. / David, G. / Gunnarsson, C. / Hao, S. / White, S. / March, J. / Zang, M. / Reynolds, M. et al. | 2011
-
PSU19 NATIONWIDE UTILIZATION PATTERN OF WHOLE BRAIN RADIOTHERAPY AND STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASISJung, S. Y. / Hwang, J. S. / Choi, J. E. / Shin, S. Y. / Kim, J. H. / Hyun, M. K. / Kim, Y. E. / Bae, J. M. et al. | 2011
-
PSU21 THE REUSE OF SINGLE-USE SURGICAL DEVICES: EVALUATION OF THE ECONOMIC EVIDENCEEmmermann, A. / Schroeer, P. / Hamerslag, L. / Kusel, J. et al. | 2011
-
PDB7 DIET THERAPIES IN PATIENTS WITH TYPE-2 DIABETES: A MIXED-TREATMENT COMPARISON OF RANDOMIZED CONTROL TRIALSHarrington, A. R. / Malone, D. et al. | 2011
-
PDB10 ASSESSING THE ABILITY OF PATIENT REPORTED MEASURES TO DISCRIMINATE PROXIES FOR TREATMENT RESPONSECantrell, R. / Brenneman, S. / Kaplan, S. / Shen, W. / Brekke, L. / Billimek, J. / Paczkowski, R. / Haynes, V. / Greenfield, S. / Buesching, D. et al. | 2011
-
PDB17 ASSOCIATION OF YOUNGER AGE WITH POOR GLYCAEMIC AND CHOLESTEROL CONTROL IN ASIANS WITH TYPE-2 DIABETES IN SINGAPOREToh, M. P. / Wu, C. X. / Heng, B. H. et al. | 2011
-
PDB41 TREATMENT GAPS AMONG GROWTH HORMONE USERS IN A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATESFincher, C. / Kozma, C. / Meletiche, D. M. / Velez, F. et al. | 2011
-
PDB54 USE OF ELECTRONIC MEDICAL RECORDS FOR CLINICAL RESEARCH IN THE MANAGEMENT OF TYPE-2 DIABETESKamal, K. M. / Civitarese, L. et al. | 2011
-
PDB56 IMPACT OF PHARMACIST MANAGEMENT ON PATIENTS WITH DIABETES ENROLLED IN A RURAL FREE CLINICFranklin, M. / Sease, J. M. / Gerrald, K. R. et al. | 2011
-
PDB59 THE COMPLEXITY OF DRUG THERAPY AND SOCIO-ECONOMIC VARIANTS IN PATIENTS WITH DIABETESZhang, J. / Tao, J. et al. | 2011
-
PMH66 MULTIMORBIDITY AND DEPRESSION TREATMENTVyas, A. / Sambamoorthi, U. et al. | 2011
-
PIH11 COST ANALYSIS OF TOTAL PARENTERAL NUTRITION IN THE NEONATAL AND PEDIATRIC CARE IN BELGIAN HOSPITALSWalter, E. / Maton, P. / Dragosits, A. / Sondhi, S. / Turpin, R. / Liu, F. X. et al. | 2011
-
PIH17 COST-EFFECTIVENESS OF ABLE A FUNCTIONAL PROGRAM TO DECREASE MORTALITY IN COMMUNITY-DWELLING OLDER ADULTSJutkowitz, E. / Gitlin, L. / Pizzi, L. T. / Lee, E. H. / Dennis, M. et al. | 2011
-
PIN8 EPIDEMIOLOGY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS AT A MIDWESTERN ACADEMIC HEALTH CARE CENTERJoshi, M. V. / Iwen, P. / Simonsen, K. / Tibbits, M. / Islam, M. et al. | 2011
-
PIN9 BUDGET IMPACT MODEL OF ABACAVIR/LAMIVUDINE FOR TREATMENT OF HIV INFECTED PATIENTS IN MEXICORely, K. / Salinas Escudero, G. / Alexandre, P. K. et al. | 2011
-
PIN47 CRITICAL SUCCESS FACTORS FOR THE UPTAKE OF NOVEL VACCINES ONTO NATIONAL IMMUNUSATION PROGRAMMESOshinowo, B. / Grosvenor, A. / Ng-Haing, J. et al. | 2011
-
PIN48 TRENDS IN FUNDING OF SPECIALIST VACCINESScott, S. A. / Forster, L. et al. | 2011
-
PMS3 RISK FACTORS FOR NON-INITIATION OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARD) BY PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS (RA)Bonafede, M. / Johnson, B. H. / Fox, K. M. / Watson, C. / Gandra, S. R. et al. | 2011
-
PMS8 THE BUDGET IMPACT OF LOWER GPA ADHERENCE IN PATIENTS WITH CHRONIC NON-STEROIDAL AND COX-2 INHIBITOR USEBonafede, M. / Johnson, B. H. / Crawley, J. / Hellmund, R. et al. | 2011
-
PMS15 COMPARING HEALTH-RISK BURDEN, LOST PRODUCTIVITY, AND TOTAL HEALTH CARE COSTS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS AND TOP FIVE CHRONIC DISEASESNaim, A. / Pitts, J. / Chen, C. Y. / Wright, D. / Edington, D. et al. | 2011
-
PMS27 A COST-EFFECTIVENESS ANALYSIS FROM AN INSTITUTIONAL PERSPECTIVE TO COMPARE ZOLEDRONIC ACID WITH STANDARD OF CARE IN THE PREVENTION OF HIP FRACTURES IN PATIENTS WITH OSTEOPOROSISBriones, B. / Bravo, M. G. / Garcí / a-Contreras, F. et al. | 2011
-
PMS32 ECONOMIC EVALUATION OF THE TREATMENT OF RHEUMATOID ARTHRITIS WITH ANTI-TNF BIOLOGICAL THERAPIES IN COLOMBIAQuintana, G. / Restrepo, J. P. / Caceres, H. A. / Rueda, J. D. / Rosselli, D. et al. | 2011
-
PMS53 USE OF TNF-INHIBITORS IN THE UNITED STATES: UTILIZATION PATTERNS AND DOSE-ESCALATION FROM A REPRESENTATIVE UNITED STATES RA POPULATIONBedenbaugh, A. / Cyhaniuk, A. / Khanna, D. et al. | 2011
-
PMS67 FREQUENCY OF SELECT ANTI-TNF ADMINISTRATION OR RE-FILL IN PATIENTS WITH RHEUMATOID ARTHRITISSchmeichel-Mueller, C. / Bartels, A. / Silver, J. / Bolge, S. / Ingham, M. et al. | 2011
-
PRS2 INCREASED PREVALENCE OF OBSTRUCTIVE LUNG DISEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEAGreenberg-Dotan, S. / Reuveni, H. / Tal, A. / Oksenberg, A. / Cohen, A. / Shaya, F. T. / Tarasiuk, A. / Scharf, S. M. et al. | 2011
-
PRS3 RELATIVE EFFECTIVENESS STUDY OF OMALIZUMAB: THE USE OF BEFORE-AFTER COHORT METHODOLOGY FOR COVERAGE WITH EVIDENCE DEVELOPMENTGrimaldi-Bensouda, L. / Zureik, M. / Molimard, M. / Aubier, M. / Abenhaim, L. et al. | 2011
-
PRS4 LITERATURE REVIEW OF RISK FACTORS FOR MORTALITY OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASECheng, Y. / Raisch, D. W. / Roberts, M. et al. | 2011
-
PRS36 HOSPITALIZATIONS, MEDICAL MANAGEMENT AND SWITCH THERAPY PATTERNS IN THE COPD MEDICARE POPULATIONEjzykowicz, F. / Hay, J. / Sarocco, P. / Karafilidis, J. / Walsh, J. et al. | 2011
-
PRS44 THE CHARIOT STUDY: NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISMArnold, R. J. / Groesser, K. / Baldwin, R. et al. | 2011
-
PRM30 RESULTS FROM A NEW VISUAL ANALOGUE SCALE PROTOCOL FOR EQ-5D VALUATIONSBailey, H. / La Foucade, A. / Kind, P. et al. | 2011
-
PRM33 TAKE TIME TO TRAIN: EVIDENCE TO SHOW THAT PATIENT TRAINING IN ELECTRONIC PATIENT REPORTED OUTCOMES IS BENEFICIALRoss, J. / Ross, E. / O'Gorman, H. J. / Peck, R. et al. | 2011
-
PCN3 CARDIOVASCULAR COMORBIDITIES AMONG PATIENTS WITH METASTATIC COLORECTAL CANCEROverbeek, J. A. / Zhao, Z. / van Herk-Sukel, M. P. / Barber, B. L. / Gao, S. / Herings, R. M. et al. | 2011
-
PCN22 ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTSRana, C. / Mann, K. / Wadhwa, A. et al. | 2011
-
PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASESBell, M. J. / Miller, J. D. / Namjoshi, M. / Russell, M. W. et al. | 2011
-
PCN52 WILLINGNESS TO PAY AND COST BENEFIT ANALYSIS OF DELIVERY METHODS FOR DECISION SUPPORT FOR RURAL CANCER PATIENTSWilson, L. S. / Loucks, A. / Franklin, L. / O'Donnell, S. / Moore, D. / Jupiter, C. / Kong, S. / Yeung, R. / Belkora, J. et al. | 2011
-
PCN57 ECONOMICS OF A MULTI-GENE ASSAY TO PREDICT RECURRENCE OF EARLY STAGE BREAST CANCER: EXPERIENCE OF A LARGE UNITED STATES INSURANCE PROGRAMHornberger, J. / Chien, R. / Kreb, K. / Hochheiser, L. I. et al. | 2011
-
PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMAPerrier, L. / Lefranc, A. / Quittet, P. / Moreau, P. / Siani, C. / Ghesquiè / res, H. / Jardin, F. / Favier, B. / Ifrah, N. et al. | 2011
-
PCN69 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT PATIENTS WITH ADVANCED PHASE CHRONIC MYELOGENOUS LEUKAEMIATaylor, M. / Lewis, L. / Lebmeier, M. / Wang, Q. et al. | 2011
-
PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPYPaulden, M. / Franek, J. / Pham, B. / Krahn, M. et al. | 2011
-
PCN90 PRO INSTRUMENTS USED TO MEASURE SYMPTOM IMPACTS OF FATIGUE AND PAIN IN PROSTATE CANCER DRUGS TRIALSPeeters, P. / Casamayor, M. / Moï / se, P. / Holmstrom, S. et al. | 2011
-
PCN113 LEARNING THE LESSONS OF ONCOLOGY HTA REVIEWS IN AUSTRALIA & THE UNITED KINGDOM – A CASE STUDY OF FIVE DRUGSLewis, S. / Dummett, H. et al. | 2011
-
PCN119 VALIDATION OF A NEW MEASURE OF PATIENT EMPOWERMENT IN ONCOLOGY: FIVE HEALTH EDUCATION IMPACT QUESTIONNAIRE (HEIQ) SCALESMaunsell, E. / Lauzier, S. / Brunet, J. / Campbell, S. / Elsworth, G. / Osborne, R. H. et al. | 2011
-
PCN118 PREDICTING THE FUTURE IMPACT OF EMERGING TECHNOLOGIES ON HEPATOCELLULAR CARCINOMA (HCC): MEASURING STAKEHOLDERS PREFERENCES WITH BEST-WORST SCALINGGallego, G. / Bridges, J. F. / Flynn, T. / Blauvelt, B. M. et al. | 2011
-
PCN130 RECORD-LINKAGE FOR PHARMACOEPIDEMIOLOGIC STUDIES IN CANCER PATIENTSvan Herk-Sukel, M. P. / Lemmens, V. / van de Poll, L. / Herings, R. M. / Coebergh, J. W. et al. | 2011
-
PGI11 THE ECONOMIC AND QUALITY OF LIFE BURDEN OF ILLNESS IN CHRONIC CONSTIPATION (CC) AND IRRITABLE BOWEL SYNDROME (IBS): A SYSTEMATIC REVIEWYee, K. / Nellesen, D. / Chawla, A. / Carson, R. / Lewis, B. et al. | 2011
-
PGI22 CONCORDANCE AMONG MULTIPLE HEALTH OUTCOMES MEASURES IN RESPONSIVENESS TO MULTI-MATRIX MESALAMINE MAINTENANCE TREATMENT FOR PATIENTS WITH QUIESCENT ULCERATIVE COLITISYen, L. / Yarlas, A. / Hodgkins, P. et al. | 2011
-
PMH39 COST-EFFECTIVENESS OF ANTIDEPRESSANT THERAPIES IN KOREAShin, S. / Jung, S. Y. / Song, H. / Park, J. / Ahn, J. et al. | 2011
-
PMH23 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH AND WITHOUT MEDICATION FOR OPIOID DEPENDENCYBaser, O. / Wang, L. / Xie, L. et al. | 2011
-
PMH30 INDIRECT COSTS (IC) OF ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 FROM THE MEDICAL EXPENDITURES PANEL SURVEY (MEPS)Kavati, A. / Rappaport, H. et al. | 2011
-
PMH38 ECONOMIC IMPLICATIONS OF THE EFFECT OF LURASIDONE VERSUS OTHER SELECTED ATYPICAL ANTIPSYCHOTICS ON CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH SCHIZOPHRENIAGuo, S. / Hernandez, L. / Green, J. / Sarocco, P. et al. | 2011
-
PMH41 ECONOMIC EVALUATION OF DESVENLAFAXINE IN THE ACUTE MANAGEMENT OF INPATIENTS WITH MAJOR DEPRESSIVE DISORDER FROM A BRAZILIAN PUBLIC HOSPITAL PERSPECTIVEScaccabarozzi, L. / Takemoto, M. L. / Fernandes, R. A. / Santos, P. M. / Tolentino, A. C. et al. | 2011
-
PMH56 COMPARISON OF DIFFERENT COMORBIDITY MEASURES FOR PREDICTING PHYSICAL AND MENTAL HEALTH IN DEMENTIAChitnis, A. / Bhowmik, D. / Dwibedi, N. / Mehta, S. / Kamble, P. / Johnson, M. L. et al. | 2011
-
PMH71 HEALTH CARE RESOURCE UTILIZATION (HRU) AND DIRECT MEDICAL EXPENDITURES (DME) FOR ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 USING MEDICAL EXPENDITURES PANEL SURVEY (MEPS)Kavati, A. / Rappaport, H. et al. | 2011
-
PND15 THE INCREMENTAL COST OF ALZHEIMER'S DISEASE IN THE CALIFORNIA MEDICAID PROGRAM (MEDI-CAL)McCombs, J. / Chu, K. / Mucha, L. et al. | 2011
-
PND39 MULTIPLE SCLEROSIS PATIENTS REPORT IMPROVEMENTS IN FATIGUE AND COGNITIVE FUNCTIONING AFTER ONE YEAR OF NATALIZUMAB TREATMENTStephenson, J. J. / Agarwal, S. S. / Kern, D. M. / Kamat, S. A. et al. | 2011
-
PND41 PARNETING STRESS IN CARING FOR CHILDREN DIAGNOSED WITH NEURO-DEVELOPMENTAL DISORDERAlmogbel, Y. S. / Goyal, R. / Sansgiry, S. et al. | 2011
-
PHP110 BIOSIMILARS LITERATURE REVIEW: THE CURRENT LANDSCAPE AND IMPLICATIONS OF RECENT HEALTH CARE LEGISLATION FOR THE UNITED STATES MARKETMaiese, B. A. / Lee, E. H. / Toscani, M. T. et al. | 2011
-
PCV45 COST-EFFECTIVENESS OF CYP2C9 AND VKORC1 GENOTYPE-GUIDED WARFARIN ANTICOAGULATION CARE: THE IMPLEMENTATION OF DISCRETE EVENT SIMULATION MODEL ON THE NATURAL HISTORY OF VENOUS THROMBOEMBOLISMTeschemaker, R. / Lawrence, W. / Wutoh, A. K. et al. | 2011
-
PCV73 CONSTRUCT VALIDITY OF HEALTH UTILITIES INDEX (HUI) JAPANESE VERSION: CROSS-SECTIONAL STUDY FOR STROKE IN JAPANNoto, S. / Uemura, T. / Izumi, R. / Moriwaki, K. et al. | 2011
-
PCV75 EFFECT OF ACEI AND ARB ON HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION AND DIABETESJohnson, M. L. / Parikh, R. / Rajan, S. S. / Aparasu, R. et al. | 2011
-
PCV92 CHANGES IN THE PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION IN GERMANY? A CLINICAL-EPIDEMIOLOGICAL EXAMINATION OF 50,000 PRIMARY CARE PATIENTS WITH THE DETECT STUDYLabeit, A. / Klotsche, J. / Pieper, L. / Wehling, M. / Wittchen, H. U. et al. | 2011
-
PCV96 TREND IN THE UTILIZATION OF PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT STRATEGIES IN THE MANAGEMENT OF NEWLY DIAGNOSED ATRIAL FIBRILLATION PATIENTS IN THE UNITED STATESKashyap, A. / Li, C. et al. | 2011
-
PCV102 COMPLICATIONS ARISING DURING HOSPITALIZATION FOR HEMORRHAGIC OR ISCHEMIC STROKE: EVIDENCE FROM A LARGE ADMINISTRATIVE DATABASECandrilli, S. D. / Karve, S. J. / Wirth, P. E. et al. | 2011
-
PSS2 DIAGNOSED AND UNDIAGNOSED DRY EYE, SYMPTOM SEVERITY, AND ASSOCIATED FACTORS AMONG MEN AND WOMEN IN THE UNITED STATESSchaumberg, D. A. / Li, J. Z. et al. | 2011
-
PSS15 DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISUAL FUNCTIONING QUESTIONNAIRE (NEI-VFQ)Kymes, S. / Peters, C. M. / Beusterien, K. / Kotak, S. / Grinspan, J. / Stwalley, D. / Pleil, A. et al. | 2011
-
PSS24 MEDICATION CHOICE AND ASSOCIATED HEALTH CARE OUTCOMES AND COSTS FOR PATIENTS WITH ACNE AND ACNE RELATED CONDITIONS IN THE UNITED STATESPatel, P. / Lin, H. C. / Feldman, S. R. / Fleischer, A. B. / Nahata, M. / Balkrishnan, R. et al. | 2011
-
PSS28 EFFECT OF DIFFERENT RECALL PERIODS ON DRY EYE SYMPTOM RATINGSRuiz, W. M. / Li, J. Z. / Johnson, M. E. et al. | 2011
-
PSY15 COSTS OF CARE FOR PRIVATELY INSURED MALES WITH HEMOPHILIA IN THE UNITED STATES, 2008Guh, S. / Grosse, S. / McAlister, S. / Kessler, C. M. / Soucie, M. et al. | 2011
-
PSY30 A REAL-WORLD EVALUATION OF ADHERENCE AND PERSISTENCE OF WEIGHT-LOSS PHARMACOTHERAPY IN THE UNITED STATES: 2007-2010Charland, S. L. / Agatep, B. C. / Aubert, R. E. / Lazzaro, J. / Stanek, E. J. et al. | 2011
-
PSY46 DISEASE SYMPTOMS, TREATMENT SATISFACTION, AND COPING STRATEGIES IN PATIENTS WITH LUPUSLerstrø / m, K. / Crimmings, M. / Govoni, M. / Nikaï / E. / Merrill, J. / Isenberg, D. et al. | 2011
-
PSY66 BIOLOGIC EXPERIENCE AND DOSING OF GOLIMUMAB PATIENTS IN MANAGED CARECarter, C. / Tandon, N. / Smith, D. et al. | 2011
-
PMD27 COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS BASED ON RESULTS FROM PHYSICIAN CASE STUDIESZubek, V. B. / Khan, F. / Karvir, H. et al. | 2011
-
PMD31 IMPACT OF GASTRIC ELECTRIC STIMULATION ON HEALTH STATE UTILITIES OF DIABETIC GASTROPARESIS PATIENTS: RESULTS FROM A PROSPECTIVE CLINICAL TRIALSoliman, A. M. / Carlson, A. / Wittek, M. R. et al. | 2011
-
PDB2 EVALUATING ONE-YEAR STABILITY OF THE TOTAL ILLNESS BURDEN INDEXBillimek, J. / Cantrell, R. / Greenfield, S. / Kaplan, S. et al. | 2011
-
PDB8 EFFECTIVENESS AND ADHERENCE WITH FIXED-DOSE COMBINATION (FDC) VERSUS COADMINISTERED DUAL THERAPY (CDT) ANTIHYPERGLYCEMIC REGIMENS: A META-ANALYSISHan, S. / Davies, M. J. / Lento, K. / Radican, L. / Zhang, Q. et al. | 2011
-
PDB18 FACTORS ASSOCIATED WITH ROUTINE PROPER MONITORING OF DIABETES CARE AMONG THE NON-INSTITUTIONALIZED POPULATION IN THE UNITED STATES: A RETROSPECTIVE ANALYSIS OF THE 2007 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)Zhao, Y. / Fonseca, V. / Shi, L. et al. | 2011
-
PDB24 DIRECT HEALTHCARE AND INDIRECT WORKLOSS COSTS ASSOCIATED WITH THE ADDITION OF ROSIGLITAZONE (RSG) VERSUS SITAGLIPTIN (STG) THERAPY TO METFORMIN (MET)Lefebvre, P. / Sarda, S. P. / Laliberté / F. / Ramamurthy, P. / Wei, R. / Arondekar, B. / Menditto, L. / Martin, A. A. / Duh, M. S. et al. | 2011
-
PDB73 A CLAIMS-BASED EMPIRIC APPROACH TO ASSESSING MEDICATION POSSESSION FOR PATIENTS INITIATING THERAPY WITH INSULINSBuysman, E. / Conner, C. / Liu, F. / Aagren, M. / Bouchard, J. et al. | 2011
-
PDB74 BETA-VERIFICATION OF A DIABETES MODELING FRAMEWORK AGAINST PUBLISHED COHORT TRIALSFuriak, N. / Bansal, M. / Gahn, J. C. / Smolen, H. et al. | 2011
-
PIH14 PROJECTING THE POTENTIAL COST-EFFECTIVENESS OF UNIVERSAL ACCESS TO MODERN CONTRACEPTIVES IN UGANDABabigumira, J. B. et al. | 2011
-
PIH15 ECONOMIC EVALUATION OF ANALGESIC MANAGEMENT AFTER TOTAL ABDOMINAL HYSTERECTOMY AT THE SOCIAL SECURITY MEXICAN INSTITUTEContreras, I. / Mould-Quevedo, J. F. / Balderas-Peñ / a, L. M. / Goycochea-Robles, M. V. / Garduñ / o-Espinosa, J. et al. | 2011
-
PIH26 MEDICATION COMPLIANCE AND ITS AFFECTING FACTORS IN CLINICAL TRIALS IN SOUTH KOREAOh, Y. / Lee, E. K. et al. | 2011
-
PIN11 EVALUATION OF COSTS AND INCOME OF AN EXTENDED TREATMENT OF CLINICAL MASTITIS CAUSED BY GRAM-POSITIVE PATHOGENS IN DAIRY COWS IN THE UNITED STATES: THE CASE OF PIRLIMYCINVan Vlaenderen, I. / Poulsen Nautrup, B. / Postorino-Reeves, N. / Gasper, S. et al. | 2011
-
PIN19 COST-BENEFIT ANALYSIS OF POSTPARTUM VACCINATION OF BIRTH MOTHERS WITH INFLUENZA VACCINEDing, Y. / Hay, J. W. / Zangwill, K. M. / Yeh, S. H. et al. | 2011
-
PIN24 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB AMONG PRETERM INFANTS COVERED BY MEDICAID IN THE UNITED STATESWeiner, L. B. / Polak, M. J. / Masaquel, A. / Mahadevia, P. J. et al. | 2011
-
PIN32 PHARMACOECONOMIC ANALYSIS OF MARAVIROC IN TREATMENT-EXPERIENCED HIV PATIENTS IN BRAZILMachado, M. / Canella, M. / Franco, E. / Zajdenverg, R. et al. | 2011
-
PIN36 ANTIRETROVIRAL REFILL ADHERENCE IN COMMUNITY HIV SPECIALTY PHARMACIES (HIV-SP) VERSUS NON-SPECIALIZED PHARMACIES (NSP)Cocohoba, J. / Murphy, P. / Pietrandoni, G. / Guglielmo, J. et al. | 2011
-
PRS7 USE OF INHALED TOBRAMYCIN IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CYSTIC FIBROSISSignorovitch, J. / Sawicki, G. S. / Zhang, J. / Latremouille-Viau, D. / Wu, E. Q. / von Wartburg, M. / Lizheng, S. et al. | 2011
-
PRS13 ECONOMIC CONSEQUENSES OF USING TULATHROMYCIN, FLORFENICOL, AND TILMICOSIN FOR TREATMENT OF CATTLE AT HIGH RISK OF DEVELOPING BOVINE RESPIRATORY DISEASE IN UNITED STATES FEEDLOTSPoulsen Nautrup, B. / Van Vlaenderen, I. / Holland, R. E. / Gasper, S. et al. | 2011
-
PRS31 DEVELOPMENT OF A QUESTIONNAIRE ASSESSING THE BURDEN OF PRURITUSTaieb, C. et al. | 2011
-
PRS35 PHARMACY QUALITY INDICATORS USING MISSISSIPPI MEDICAID: TESTING PQA-ENDORSED STARTER SET MEASURES AND 2010 TEST MEASURESThumula, V. / Banahan, B. F. / Bentley, J. P. / West-Strum, D. et al. | 2011
-
PRS39 EFFECT OF BIOMASS SMOKE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN RURAL LOCALITIES OF COLOMBIAAlvis, N. / Paternina, A. / Montes, J. / De la Hoz, F. et al. | 2011
-
PRM25 PSYCHOMETRIC COMPARIBILITY OF SINGLE ITEM AND GRID FORM ADMINISTRATION OF THE SF-36V2™ HEALTH SURVEYSmith, K. J. / Kosinski, M. et al. | 2011
-
PRM26 IMPACT OF A WEB PORTAL TOOL ON DRIVING PATIENT ADHERENCEYing, X. / Khandelwal, N. / Korcheck, R. / Duncan, I. et al. | 2011
-
PRM39 LITERATURE REVIEW OF RANDOMIZED, CONTROLLED STUDIES OF THE IMPACT OF PHARMACISTS' INTERVENTIONS TO IMPROVE PATIENT OUTCOMESKharat, A. A. / Borrego, M. / Raisch, D. W. et al. | 2011
-
PCN31 DIRECT MEDICAL COSTS OF ELDERLY PATIENTS WITH STAGE III COLON CANCER DURING FIRST-LINE VERSUS SECOND-LINE CHEMOTHERAPYYang, H. K. / Bikov, K. / Onukwugha, E. / Mullins, C. D. et al. | 2011
-
PCN64 ECONOMIC EVALUATION OF THREE FORMULATIONS OF LEUPROLIDE ACETATE IN ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER IN BELGIUMWex, J. / Sidhu, M. / Odeyemi, I. / Retsa, P. et al. | 2011
-
PCN74 UTILISATION OF DRUGS INVOLVED IN TREATMENT OF STAGE I AND STAGE II BREAST CANCER IN SLOVAK REPUBLICGatialova, K. / Bellova, K. / Majtas, J. / Foltan, V. / Petrova, L. et al. | 2011
-
PCN78 THE DEVELOPMENT OF A VALUE BASED PRICING INDEX FOR NEW DRUGS IN METASTATIC COLORECTAL CANCERDranitsaris, G. / Truter, I. / Lubbe, M. et al. | 2011
-
PCN114 DEVELOPING A FAMILIAL CANCER RISK ASSESSMENT TOOL FOR USE IN UNDERSERVED COMMUNITIESBhattacharjee, S. / Westman, J. A. / Kelly, K. M. et al. | 2011
-
PCN116 TRANSFERABILITY OF NICE RECOMMENDATIONS FOR PHARMACEUTICAL THERAPIES IN ONCOLOGY TO CENTRAL-EASTERN EUROPEAN COUNTRIESKalo, Z. / Landa, K. / Dolezal, T. / Vokó / Z. et al. | 2011
-
PCN124 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED AT PUBLIC ONCOLOGY CLINICS IN SÃO PAULO, BRAZILTakemoto, M. L. / Takemoto, M. M. / Fernandes, R. A. / Tolentino, A. C. / Santos, P. M. et al. | 2011
-
PGI14 PERCEIVED VALUE ASSESSMENT OF ENTECAVIR VERSUS TENOFOVIR IN CHRONIC HEPATITIS BVorobyev, P. / Telegina, I. / Borisenko, O. / Jakouloff, D. et al. | 2011
-
PGI19 HEALTH-RELATED QUALITY OF LIFE IS LOWER FOR PATIENTS WITH DIURNAL AND NOCTURNAL GERD SYMPTOMSGoren, A. / Gupta, S. / Balu, S. / Buchner, D. et al. | 2011
-
PMH17 PREVALENCE OF ANTICHOLINERGIC DRUG PRESCRIBING IN ELDERLY OUTPATIENTS WITH DEMENTIABhattacharya, R. / Chatterjee, S. / Aparasu, R. et al. | 2011
-
PMH43 ECONOMIC IMPACT OF CYP450 PHARMACOGENETIC TESTING ON DEPRESSION TREATMENTSyeda, S. S. / Wu, W. K. et al. | 2011
-
PMH75 PSYCHIATRIC MORBIDITY AND BURNOUT AMONG HOSPITAL PHYSICIANS AND NURSES: ASSOCIATION WITH PERCEIVED JOB-RELATED FACTORSTabolli, S. / di Pietro, C. / Renzi, C. et al. | 2011
-
PND5 ASSESSMENT OF PARKINSON'S DISEAES PROGRESSION RATES BY STAGE OF DISEASEJohnson, S. J. / Kaltenboeck, A. / Diener, M. / Tarrants, M. / Birnbaum, H. et al. | 2011
-
PND8 INCIDENCE RATES OF SUBARACHNOID HEMORRHAGE IN PATIENTS WITH UNRUPTURED ANEURYSM IN SOUTH KOREA FROM 2006-2009Lee, E. J. / Kwon, J. W. / Lee, H. J. / Hyun, M. K. / Hwang, J. S. / Kim, J. / Choi, J. / Lee, N. R. et al. | 2011
-
PND13 BURDEN OF ILLNESS IN THE UNITED STATES FOR PEDIATRIC EPILEPSY PATIENTS WITH PARTIAL ONSET SEIZURES RECEIVING ANTI-EPILEPTIC DRUGSCopher, R. / Angalakuditi, M. et al. | 2011
-
PND22 QUANTIFYING COST OUTCOMES DIFFERENTIATED BY GENDER AND AGE IN THE TREATMENT OF MIGRAINE HEADACHE USING STEP AND STRATIFIED CAREFuriak, N. / Bansal, M. et al. | 2011
-
PND35 CREATION OF A WEB-BASED MULTIPLE SCLEROSIS PATIENT-REPORTED OUTCOMES RESEARCH PROGRAMDeering, K. / Agarwal, S. S. / Rajagopalan, K. / Harshaw, Q. / Shillington, A. C. et al. | 2011
-
PND45 ONE YEAR OF NATALIZUMAB TREATMENT IS ASSOCIATED WITH AN IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTSStephenson, J. J. / Agarwal, S. S. / Kern, D. M. / Kamat, S. A. et al. | 2011
-
PND62 MEDICATION POSSESSION RATIO (MPR): A COMPARISON OF TRADITIONAL MPR AND MODIFIED MPR FOR MULTIPLE SCLEROSIS (MS) PATIENTS PRESCRIBED DISEASE MODIFYING DRUGS (DMDS)Dickson, M. / Kozma, C. / Phillips, A. / Meletiche, D. M. et al. | 2011
-
PND60 TESTING A COMPUTERIZED METHOD OF ASSESSING MOVEMENT ACCURACYAllen, D. D. / Ng, M. / Greenwald, C. P. et al. | 2011
-
CO4 POTENTIAL COST SAVINGS FROM COMPARATIVE EFFECTIVENESS RESEARCH: LESSONS FROM COURAGE STUDYBonakdar tehrani, A. / Howard, D. et al. | 2011
-
IN2 ASSOCIATION BETWEEN DRUG TOLERABILITY AND ECONOMIC IMPACT FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTGao, X. / Ji, X. / Stephens, J. M. / Schlamm, H. / Tarallo, M. et al. | 2011
-
IN3 COSTS ASSOCIATED WITH HCV AND RELATED COMPLICATIONS IN THE UNITED STATES FROM A MANAGED CARE PAYER'S PERSPECTIVEMcAdam Marx, C. / Hane, C. A. / Biskupiak, J. / Deniz, B. / McGarry, L. / Brixner, D. et al. | 2011
-
EE1 SYSTEMATIC REVIEW OF GUIDELINES FOR HEALTH ECONOMIC EVALUATIONSMelnyk, P. / Wagner, M. / Dourdin, N. / Rindress, D. et al. | 2011
-
EE3 PERFORMANCE OF DIFFERENT COMORBIDITY MEASURES IN PREDICTING HEALTH CARE EXPENDITURE IN PATIENTS WITH DEMENTIAJohnson, M. L. / Mehta, S. / Chitnis, A. S. / Bhowmik, D. / Dwibedi, N. / Kamble, P. et al. | 2011
-
PHP8 PHYSICIAN SHORTAGE IMPACT ON PATIENT RX USE FOR SELECT CHRONIC CONDITIONSDall, T. / Seiders, M. / Price, P. / Chakrabarti, R. / Tal, S. / Kowal, S. / Larson, J. et al. | 2011
-
PHP60 ORPHAN DRUGS FACE TOUGHER SCRUTINY IN SECURING FAVORABLE PRICING AND MARKET ACCESSGrosvenor, A. / Saraf, S. / Jones, K. et al. | 2011
-
PHP61 WIDER CONSULTATION IN HEALTH TECHNOLOGY ASSESSMENT (HTA) DECISIONS: BETTER UNDERSTANDING OR A LOBBYING OPPORTUNITY?Bending, M. W. / Hutton, J. / McGrath, C. et al. | 2011
-
PHP71 IMPACT OF THE MEDICARE PART D COVERAGE GAP ON PRESCRIPTION DRUG UTILIZATION AND MEDICATION ADHERENCENaik, R. / Borrego, M. / Dodd, M. / Raisch, D. / Khan, N. / Bakhireva, L. / Gupchup, G. / Cunico, L. et al. | 2011
-
PHP97 PRO LABEL CLAIMS: AN ANALYSIS BASED ON A REVIEW OF PROS AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010Mordin, M. / Clark, M. / DeMuro, C. / Evans, E. / Copley-Merriman, K. / Fehnel, S. / Gnanasakthy, A. et al. | 2011
-
PHP105 HOW ARE COVERAGE DECISIONS MADE IN PUBLICLY FUNDED HEALTH CARE PROGRAMS IN LOW- AND MIDDLE-INCOME COUNTRIES?Hornberger, J. / Shewade, A. / Gutierrez, H. et al. | 2011
-
PHP111 OVER INFLATION OF THE GENETIC CONTRIBUTION TO SCHIZOPHRENIA: IMPLICATIONS FOR NOVEL THERAPEUTICSFleming, M. / Martin, C. R. et al. | 2011
-
PCV59 PERSISTENCE AND COMPLIANCE IN HYPERTENSIVE PATIENTS TREATED WITH FIXED OR UNFIXED COMBINATIONS OF ANGIOTENSIN RECEPTOR BLOCKERS, AMPLODIPINE AND HYDROCHLOROTHIAZIDESandberg, A. / Kostev, K. / Ehlken, B. / Holz, B. / Oberdiek, A. et al. | 2011
-
PSY35 VALIDATION OF THE LUPUS IMPACT TRACKERJolly, M. / Kosinski, M. / Garris, C. P. / Jhingran, P. M. / Mikolaitis, R. A. / Dennis, G. / Wallace, D. J. / Clarke, A. / Parke, A. / Dooley, M. A. et al. | 2011
-
PCV82 EVALUATION OF RELATIONSHIP BETWEEN BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS AND INTEGRATION OF SERVICES WITHIN PHYSICIAN ORGANIZATIONSSmalarz, A. / Fraser, K. / Wong, K. / Wu, N. / Wogen, J. / Boulanger, L. et al. | 2011
-
PSS6 SAFETY PROFILE OF LATANOPROST VERSUS TIMOLOL IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION: POST 2000 SETTINGGupta, J. / Siddiqui, M. K. / Jindal, R. / Sehgal, M. et al. | 2011
-
PSS9 COST-EFFECTIVENESS OF COLLAGENASE VERSUS HYDROGEL DRESSINGS FOR CHRONIC-WOUND DEBRIDEMENT IN A LONG-TERM CARE SETTINGWaycaster, C. et al. | 2011
-
PSY5 AN INVESTIGATION INTO THE RELATIONSHIP BETWEEN OBESITY AND SKIN AND SOFT TISSUE INFECTIONS REQUIRING HOSPITALIZATIONSwiney, J. et al. | 2011
-
PSY17 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICOArocho, R. / Northridge, K. / Rivera Hurtado, R. / Garcí / a Chá / vez, J. et al. | 2011
-
PSY23 ECONOMIC EVALUATION OF ERYTHROPOIESIS STIMULATING AGENTS IN CRITICALLY ILL TRAUMA PATIENTSChui, B. K. / Hazel, M. / Dong, J. / Klarenbach, S. et al. | 2011
-
PSY49 PREDICTORS OF OBESITY TREATMENT (COUNSELING OR PHARMACOTHERAPY) IN AMBULATORY SETTINGSMehta, H. B. / Patel, J. / Parikh, R. / Abughosh, S. et al. | 2011
-
PSY57 DOES CLINICAL DIAGNOSIS OF OBESITY INCREASE THE LIKELIHOOD OF RECEIVING OBESITY RELATED COUNSELING? A 2005-2008 NAMCS-NHAMCS ANALYSISKadakia, A. / Mehta, H. / Rajan, S. S. / Abughosh, S. et al. | 2011